Equitable Holdings, Inc. EQH-PC Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001333986-25-000020
cik 1333986
name EQUITABLE HOLDINGS, INC.
sic 6411
countryba US
stprba NY
cityba NEW YORK
zipba 10105
bas1 1345 AVENUE OF THE AMERICAS
bas2
baph (212) 554-1234
countryma US
stprma NY
cityma NEW YORK
zipma 10105
mas1 1345 AVENUE OF THE AMERICAS
mas2
countryinc US
stprinc DE
ein 585512450
former AXA EQUITABLE HOLDINGS, INC.
changed 20171107
afs 1-LAF
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250501
accepted 2025-05-01 15:17:00.0
prevrpt 0
detail 1
instance eqh-20250331_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001333986-25-000020 20240331 Accumulated Other Comprehensive Income Loss Net Of Tax -8166000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Accumulated Other Comprehensive Income Loss Net Of Tax -6000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax 0.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax -7567000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001333986-25-000020 20240331 Annuities And Investment Certificates Transfer To From Separate Accounts 401000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20250331 Annuities And Investment Certificates Transfer To From Separate Accounts 484000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20240331 Assets 285577000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Assets 298989000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Assets 85000000.0000 USD 0 us-gaap/2024 Consolidated Entities= Consolidated Entity; Equity Method Investment Nonconsolidated Investee= A B Sponsored Investment Funds;
0001333986-25-000020 20250331 Assets 287366000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20250331 Assets 2400000000.0000 USD 0 us-gaap/2024 Consolidated Entities= Consolidated Limited Partnerships;
0001333986-25-000020 20240630 Benefits Losses And Expenses 2826000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240630 Benefits Losses And Expenses 4837000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20240630 Benefits Losses And Expenses 25000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Benefits Losses And Expenses 7921000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20241231 Benefits Losses And Expenses 10326000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20221231 Comprehensive Income Net Of Tax 46000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Comprehensive Income Net Of Tax -1000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Comprehensive Income Net Of Tax -326000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Comprehensive Income Net Of Tax -6000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Comprehensive Income Net Of Tax -7000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20221231 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 0.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 0.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 230000000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 99000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20241231 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 514000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest -28000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20231231 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 2828000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20240331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest -27000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= U S Treasury And Government;
0001333986-25-000020 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 4520000000.0000 USD 0 us-gaap/2024 Financial Instrument= Residential Mortgage Backed Securities;
0001333986-25-000020 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 684000000.0000 USD 0 us-gaap/2024 Financial Instrument= Foreign Government Debt Securities;
0001333986-25-000020 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Redeemable Preferred Stock;
0001333986-25-000020 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Residential Mortgage Backed Securities;
0001333986-25-000020 20241231 Debt Securities Available For Sale Excluding Accrued Interest 4288000000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Government Debt Securities;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 389000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 1831000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Public Corporate;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 389000000.0000 USD 0 us-gaap/2024 Financial Instrument= U S States And Political Subdivisions;
0001333986-25-000020 20231231 Deferred Income Tax Assets Net 2054000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20241231 Deferred Income Tax Assets Net 6000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Deferred Policy Acquisition Cost Amortization Expense Net Investment Gains Losses 0.0000 USD 1 us-gaap/2024 Business Segments= Asset Management; Consolidation Items= Operating Segments;
0001333986-25-000020 20250331 Deferred Policy Acquisition Cost Amortization Expense Net Investment Gains Losses 188000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20250331 Deferred Policy Acquisition Cost Amortization Expense Net Investment Gains Losses 15000000.0000 USD 1 us-gaap/2024 Business Segments= Legacy; Consolidation Items= Operating Segments;
0001333986-25-000020 20250331 Deferred Policy Acquisition Cost Amortization Expense Net Investment Gains Losses 32000000.0000 USD 1 us-gaap/2024 Business Segments= Protection Solutions; Consolidation Items= Operating Segments;
0001333986-25-000020 20231231 Deferred Policy Acquisition Costs 1571000000.0000 USD 0 us-gaap/2024 Business Segments= Individual Retirement; Product Or Service= Structured Capital Strategies;
0001333986-25-000020 20240331 Deferred Policy Acquisition Costs 747000000.0000 USD 0 us-gaap/2024 Business Segments= Group Retirement; Product Or Service= E Q U I V E S T Group;
0001333986-25-000020 20241231 Deferred Policy Acquisition Costs 768000000.0000 USD 0 us-gaap/2024 Business Segments= Group Retirement; Product Or Service= E Q U I V E S T Group;
0001333986-25-000020 20241231 Deferred Policy Acquisition Costs 83000000.0000 USD 0 us-gaap/2024 Business Segments= Group Retirement; Product Or Service= Momentum;
0001333986-25-000020 20241231 Deferred Policy Acquisition Costs 186000000.0000 USD 0 us-gaap/2024 Business Segments= Protection Solutions; Product Or Service= Indexed Universal Life;
0001333986-25-000020 20241231 Deferred Policy Acquisition Costs 314000000.0000 USD 0 us-gaap/2024 Business Segments= Protection Solutions; Product Or Service= Term;
0001333986-25-000020 20241231 Deferred Policy Acquisition Costs 1083000000.0000 USD 0 us-gaap/2024 Business Segments= Protection Solutions; Product Or Service= Variable Universal Life;
0001333986-25-000020 20250331 Deferred Policy Acquisition Costs 82000000.0000 USD 0 us-gaap/2024 Business Segments= Group Retirement; Product Or Service= Momentum;
0001333986-25-000020 20240331 Derivative Gain Loss On Derivative Net -1115000000.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Equity Swap; Hedging Designation= Nondesignated;
0001333986-25-000020 20250331 Derivative Gain Loss On Derivative Net 799000000.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Derivative Instruments Including Embedded Derivative;
0001333986-25-000020 20250331 Derivative Gain Loss On Derivative Net -23000000.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Interest Rate Futures; Hedging Designation= Nondesignated;
0001333986-25-000020 20250331 Dividends Common Stock 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001333986-25-000020 20240331 Dividends Preferred Stock 0.0000 USD 1 us-gaap/2024 Equity Components= Preferred Stock Including Additional Paid In Capital;
0001333986-25-000020 20221231 Earnings Per Share Basic 5.4600 USD 4 us-gaap/2024
0001333986-25-000020 20221231 Earnings Per Share Basic -0.0300 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Earnings Per Share Basic -0.0600 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20231231 Earnings Per Share Basic 3.4900 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Earnings Per Share Basic 1.2400 USD 1 us-gaap/2024
0001333986-25-000020 20240630 Earnings Per Share Basic -0.0600 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20221231 Earnings Per Share Diluted 5.4600 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20231231 Earnings Per Share Diluted 3.4800 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Earnings Per Share Diluted -0.0900 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20231231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 6000000.0000 USD 0 us-gaap/2024 Financing Receivable Recorded Investment By Class Of Financing Receivable= Agricultural Mortgage Loans;
0001333986-25-000020 20240331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 6000000.0000 USD 0 us-gaap/2024 Financing Receivable Recorded Investment By Class Of Financing Receivable= Agricultural Mortgage Loans;
0001333986-25-000020 20240331 Gain Loss On Sale Of Business 1000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20250331 Gain Loss On Sale Of Business 0.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240331 Gains Loss On Investments And Disposition Of Business -18000000.0000 USD 1 0001333986-25-000020 Investment Type= Mortgages;
0001333986-25-000020 20250331 Gains Loss On Investments And Disposition Of Business 1000000.0000 USD 1 0001333986-25-000020 Investment Type= Other Investments;
0001333986-25-000020 20241231 Goodwill And Other Intangible Assets Net 5371000000.0000 USD 0 0001333986-25-000020
0001333986-25-000020 20240331 Income Loss Due To Novation In Pre Tax Net Income 0.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20250331 Income Loss Due To Novation In Pre Tax Net Income 499000000.0000 USD 1 0001333986-25-000020 Product Or Service= Novation;
0001333986-25-000020 20230630 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 539000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 80000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Income Tax Expense Benefit -292000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230930 Income Tax Expense Benefit -6000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Income Tax Expense Benefit 30000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Income Tax Expense Benefit -6000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20231231 Increase Decrease In Accrued Income Taxes Payable -1168000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20240930 Increase Decrease In Accrued Income Taxes Payable -5000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20221231 Increase Decrease In Employee Related Liabilities -11000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Increase Decrease In Reinsurance Recoverable 2000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Increase Decrease In Reinsurance Recoverable 612000000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Increase Decrease In Reinsurance Recoverable 868000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20250331 Increase Decrease In Securities Lending Payable 9000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240331 Insurance Commissions 437000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240331 Insurance Commissions 173000000.0000 USD 1 us-gaap/2024 Business Segments= Asset Management; Consolidation Items= Operating Segments;
0001333986-25-000020 20240331 Insurance Commissions 44000000.0000 USD 1 us-gaap/2024 Business Segments= Group Retirement; Consolidation Items= Operating Segments;
0001333986-25-000020 20240331 Insurance Commissions -200000000.0000 USD 1 us-gaap/2024 Consolidation Items= Intersegment Elimination;
0001333986-25-000020 20250331 Insurance Commissions 201000000.0000 USD 1 us-gaap/2024 Business Segments= Asset Management; Consolidation Items= Operating Segments;
0001333986-25-000020 20250331 Insurance Commissions 43000000.0000 USD 1 us-gaap/2024 Business Segments= Group Retirement; Consolidation Items= Operating Segments;
0001333986-25-000020 20250331 Insurance Commissions 6000000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001333986-25-000020 20221231 Interest Credited To Policyholders Account Balances 5000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Interest Credited To Policyholders Account Balances 964000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230930 Interest Credited To Policyholders Account Balances 1500000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20240630 Interest Credited To Policyholders Account Balances 1171000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Interest Credited To Policyholders Account Balances 701000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20241231 Investments 116447000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20250331 Investments 131000000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Underlying Asset Class= Collateralized Loan Obligations;
0001333986-25-000020 20241231 Investments Fixed Maturities Fair Value Option Variable Interest Entity 1778000000.0000 USD 0 0001333986-25-000020 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001333986-25-000020 20230630 Labor And Related Expense 1144000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20230630 Labor And Related Expense 1149000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230930 Labor And Related Expense 593000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Liabilities 292791000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20231231 Liabilities And Stockholders Equity 276814000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Liability For Future Policy Benefit Remeasurement Gain Loss 7000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240630 Liability For Future Policy Benefit Remeasurement Gain Loss -1000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20231231 Liability For Future Policy Benefits 17374000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20241231 Liability For Future Policy Benefits 17613000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20241231 Liability For Future Policy Benefits 901000000.0000 USD 0 us-gaap/2024 Product Or Service= Other Future Policyholder Benefits;
0001333986-25-000020 20241231 Liability For Future Policy Benefits 2105000000.0000 USD 0 us-gaap/2024 Product Or Service= Other Policyholder Funds And Dividends Payable;
0001333986-25-000020 20250331 Liability For Future Policy Benefits 4782000000.0000 USD 0 us-gaap/2024 Business Segments= Individual Retirement; Consolidation Items= Operating Segments; Product Or Service= Payout;
0001333986-25-000020 20250331 Liability For Future Policy Benefits 1292000000.0000 USD 0 us-gaap/2024 Business Segments= Protection Solutions; Consolidation Items= Operating Segments; Product Or Service= Term;
0001333986-25-000020 20250331 Liability For Future Policy Benefits 908000000.0000 USD 0 us-gaap/2024 Product Or Service= Other Future Policyholder Benefits;
0001333986-25-000020 20250331 Loans Insurance Policy 4553000000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001333986-25-000020 20240630 Market Risk Benefit Asset Amount -4000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Market Risk Benefit Change In Fair Value Gain Loss 945000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20230930 Market Risk Benefit Change In Fair Value Gain Loss 1772000000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20231231 Market Risk Benefit Change In Fair Value Gain Loss 8000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Market Risk Benefit Change In Fair Value Gain Loss 133000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Market Risk Benefit Change In Fair Value Gain Loss -97000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20231231 Market Risk Benefit Liability Amount 18000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Market Risk Benefit Liability Amount 62000000.0000 USD 0 us-gaap/2024 Business Segments= All Other Segments;
0001333986-25-000020 20250331 Market Risk Benefit Liability Amount 1129000000.0000 USD 0 us-gaap/2024 Business Segments= Individual Retirement; Product Or Service= Core1;
0001333986-25-000020 20250331 Market Risk Benefit Liability Amount 9650000000.0000 USD 0 us-gaap/2024 Business Segments= Legacy; Product Or Service= Gross Legacy;
0001333986-25-000020 20231231 Minority Interest 1739000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240331 Minority Interest 1723000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001333986-25-000020 20240331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001333986-25-000020 20250331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001333986-25-000020 20240930 Net Cash Provided By Used In Operating Activities 0.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20221231 Net Income Loss -13000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Net Income Loss -4000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Net Income Loss -16000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Net Income Loss 92000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240930 Net Income Loss 2000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Net Income Loss Attributable To Noncontrolling Interest 0.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Net Income Loss Attributable To Noncontrolling Interest 71000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Net Income Loss Attributable To Noncontrolling Interest 103000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240630 Net Income Loss Attributable To Noncontrolling Interest 240000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Net Income Loss Attributable To Noncontrolling Interest 0.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20221231 Net Income Loss Available To Common Stockholders Basic -13000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Net Income Loss Available To Common Stockholders Basic 2000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Net Income Loss Available To Common Stockholders Basic 334000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20221231 Net Income Loss Available To Common Stockholders Diluted 2073000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20250331 Net Income Loss Available To Common Stockholders Diluted 49000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240331 Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest 177000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20241231 Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest 1280000000.0000 USD 4 0001333986-25-000020 Equity Components= Retained Earnings;
0001333986-25-000020 20250331 Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest 0.0000 USD 1 0001333986-25-000020 Equity Components= Common Stock;
0001333986-25-000020 20250331 Notes Issued By Consolidated Variable Interest Entity Fair Value Option 1931000000.0000 USD 0 0001333986-25-000020 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001333986-25-000020 20221231 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax1 -12606000000.0000 USD 4 0001333986-25-000020 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax1 -37000000.0000 USD 2 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax1 -54000000.0000 USD 3 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20231231 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax1 2379000000.0000 USD 4 0001333986-25-000020
0001333986-25-000020 20240630 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax1 -408000000.0000 USD 1 0001333986-25-000020 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax1 1000000.0000 USD 1 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk 5000000.0000 USD 1 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk 87000000.0000 USD 1 0001333986-25-000020 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230930 Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk 243000000.0000 USD 3 0001333986-25-000020
0001333986-25-000020 20240630 Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk 159000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20240630 Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk 128000000.0000 USD 2 0001333986-25-000020 Restatement= Scenario Previously Reported;
0001333986-25-000020 20221231 Other Comprehensive Income Loss Net Of Tax 59000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Other Comprehensive Income Loss Net Of Tax -24000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Other Comprehensive Income Loss Net Of Tax -2698000000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001333986-25-000020 20240331 Other Comprehensive Income Loss Net Of Tax -389000000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Preferred Stock Including Additional Paid In Capital;
0001333986-25-000020 20240331 Other Comprehensive Income Loss Net Of Tax -5000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Other Comprehensive Income Loss Net Of Tax -393000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20250331 Other Comprehensive Income Loss Net Of Tax 1145000000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001333986-25-000020 20221231 Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax -19000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20230630 Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax 1000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax -18000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax -11000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax -29000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20240630 Other Cost And Expense Operating 980000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Other Depreciation Amortization And Accretion -21000000.0000 USD 2 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20231231 Other Depreciation Amortization And Accretion -9000000.0000 USD 4 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Other Depreciation Amortization And Accretion -240000000.0000 USD 1 0001333986-25-000020 Restatement= Scenario Previously Reported;
0001333986-25-000020 20221231 Other Income 1010000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20221231 Other Income -18000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Other Income 258000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Other Income 429000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Other Income -5000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Other Income 1298000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20241231 Other Income -7000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Other Income 1305000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Other Investment Income Loss 1036000000.0000 USD 1 0001333986-25-000020 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Other Investment Income Loss 8000000.0000 USD 2 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Other Investment Income Loss 6000000.0000 USD 3 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Other Investment Income Loss 0.0000 USD 1 0001333986-25-000020 Derivative Instrument Risk= Currency Foward; Hedging Designation= Nondesignated;
0001333986-25-000020 20240331 Other Investment Income Loss 3000000.0000 USD 1 0001333986-25-000020 Derivative Instrument Risk= Interest Rate Swap; Derivative Instruments Gain Loss By Hedging Relationship= Cash Flow Hedging; Hedging Designation= Designated As Hedging Instrument;
0001333986-25-000020 20240331 Other Investment Income Loss 0.0000 USD 1 0001333986-25-000020 Derivative Instrument Risk= Stock Option; Hedging Designation= Nondesignated;
0001333986-25-000020 20241231 Other Investment Income Loss -15000000.0000 USD 4 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20250331 Other Investment Income Loss 0.0000 USD 1 0001333986-25-000020 Derivative Instrument Risk= Credit Default Swap; Hedging Designation= Nondesignated;
0001333986-25-000020 20241231 Other Investments 8537000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240331 Other Liabilities 6401000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240331 Other Liabilities -110000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Other Noncash Income Expense 4000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Payables To Customers 1933000000.0000 USD 0 srt/2024
0001333986-25-000020 20240331 Payments For Proceeds From Derivative Instrument Investing Activities 1179000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240331 Payments For Proceeds From Other Investing Activities -394000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20250331 Payments Of Dividends Preferred Stock And Preference Stock 14000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20250331 Payments Of Market Risk Benefits 154000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20230930 Policyholder Benefits And Claims Incurred Net 2108000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20240930 Policyholder Contract Deposits 107404000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20241231 Policyholder Contract Deposits 110965000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20250331 Policyholder Contract Deposits 112793000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20230630 Preferred Stock Dividends And Other Adjustments 26000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Preferred Stock Dividends And Other Adjustments 40000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20231231 Preferred Stock Dividends And Other Adjustments 80000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Preferred Stock Dividends And Other Adjustments 54000000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Preferred Stock Dividends And Other Adjustments 80000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20250331 Preferred Stock Liquidation Preference Value 25000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20230630 Premiums Earned Net 280000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Premiums Earned Net 282000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Premiums Earned Net 10000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Premiums Earned Net 557000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20250331 Premiums Earned Net 304000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20250331 Proceeds From Issuance Of Long Term Debt 495000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240331 Proceeds From Sale And Collection Of Mortgage Notes Receivable 256000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20221231 Profit Loss 2381000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20221231 Profit Loss 2394000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230930 Profit Loss 2212000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20240930 Profit Loss 788000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20250331 Profit Loss 150000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20231231 Purchased Market Risk Benefits 28000000.0000 USD 0 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Purchased Market Risk Benefits 7993000000.0000 USD 0 0001333986-25-000020 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Purchase Of Noncontrolling Interests For Share Based Compensation Plan 6000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20231231 Redeemable Noncontrolling Interest Equity Carrying Amount 770000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20250331 Redeemable Noncontrolling Interest Equity Carrying Amount 189000000.0000 USD 0 us-gaap/2024 Consolidated Entities= Consolidated Entity; Equity Method Investment Nonconsolidated Investee= A B Sponsored Investment Funds;
0001333986-25-000020 20240630 Reinsurance Payable 1363000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20231231 Reinsurance Recoverables On Paid Losses 8197000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240331 Reinsurance Recoverables On Paid Losses 8252000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240930 Reinsurance Recoverables On Paid Losses 8222000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Repayments Of Annuities And Investment Certificates 2572000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20250331 Repayments Of Annuities And Investment Certificates 2059000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20250331 Repayments Of Collateralized Loan Obligations 24000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20240930 Retained Earnings Accumulated Deficit 9977000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Revenues 2363000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230630 Revenues 2377000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Revenues -3000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Revenues 3073000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240930 Revenues 3076000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Revenues -6000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Revenues 12437000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Separate Account Assets 0.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Separate Account Assets 137407000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Separate Account Assets 1036000000.0000 USD 0 us-gaap/2024 Product Or Service= Corp And Other; Separate Account Asset Category= Separate Account Bonds And Notes;
0001333986-25-000020 20241231 Separate Account Assets 13000000.0000 USD 0 us-gaap/2024 Product Or Service= Corp And Other; Separate Account Asset Category= Separate Account Debt Security;
0001333986-25-000020 20241231 Separate Account Assets 33214000000.0000 USD 0 us-gaap/2024 Product Or Service= Legacy Segment;
0001333986-25-000020 20241231 Separate Account Assets 98000000.0000 USD 0 us-gaap/2024 Product Or Service= Protection Solutions; Separate Account Asset Category= Separate Account Bonds And Notes;
0001333986-25-000020 20250331 Separate Account Assets 35000000.0000 USD 0 us-gaap/2024 Product Or Service= Individual Retirement; Separate Account Asset Category= Separate Account Common Stock;
0001333986-25-000020 20250331 Separate Account Assets 0.0000 USD 0 us-gaap/2024 Product Or Service= Legacy Segment; Separate Account Asset Category= Separate Account Common Stock;
0001333986-25-000020 20231231 Separate Accounts Liability 26959000000.0000 USD 0 us-gaap/2024 Business Segments= Group Retirement; Product Or Service= E Q U I V E S T Group;
0001333986-25-000020 20240331 Separate Accounts Liability 34860000000.0000 USD 0 us-gaap/2024 Business Segments= Legacy Segment; Product Or Service= Gross Legacy;
0001333986-25-000020 20240930 Separate Accounts Liability 137407000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20241231 Separate Accounts Liability 4885000000.0000 USD 0 us-gaap/2024 Business Segments= Individual Retirement; Product Or Service= Investment Edge;
0001333986-25-000020 20241231 Separate Accounts Liability 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001333986-25-000020 20241231 Separate Accounts Liability 12055000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001333986-25-000020 20250331 Separate Accounts Liability 11388000000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001333986-25-000020 20241231 Short Term Borrowings 0.0000 USD 0 us-gaap/2024 Short Term Debt Type= Commercial Paper;
0001333986-25-000020 20240331 Stockholders Equity 1992000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240630 Stockholders Equity 1644000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 11920000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -58000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Restatement Adjustment;
0001333986-25-000020 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 40000000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Restatement Adjustment;
0001333986-25-000020 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 8413000000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Scenario Previously Reported;
0001333986-25-000020 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -7000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 26000000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Restatement Adjustment;
0001333986-25-000020 20230331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 22000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 5471000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -7165000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001333986-25-000020 20230630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3552000000.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0001333986-25-000020 20230630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 10347000000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001333986-25-000020 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -6723000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss; Net Unrealized Investment Gains Losses= A O C I Gains Losses Related To Net Unrealized Investment Gains Losses; Unrealized Investment Gains Losses With O T T I And All Other= Unrealized Investment Gains Losses All Other;
0001333986-25-000020 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 50000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss; Net Unrealized Investment Gains Losses= Policyholders Liabilities; Unrealized Investment Gains Losses With O T T I And All Other= Unrealized Investment Gains Losses All Other;
0001333986-25-000020 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -13000000.0000 USD 0 us-gaap/2024 Equity Components= Parent; Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2322000000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001333986-25-000020 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1562000000.0000 USD 0 us-gaap/2024 Equity Components= Preferred Stock Including Additional Paid In Capital;
0001333986-25-000020 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3755000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -8675000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001333986-25-000020 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -8712000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001333986-25-000020 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1858000000.0000 USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001333986-25-000020 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -386000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Gain Loss Financial Liability Market Risk Benefit Including Portion Attributable To Noncontrolling Interest;
0001333986-25-000020 20250331 Stockholders Equity Other 44000000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001333986-25-000020 20250331 Stockholders Equity Other 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001333986-25-000020 20240331 Stock Issued During Period Value Treasury Stock Reissued 17000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20250331 Stock Issued During Period Value Treasury Stock Reissued 20000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20250331 Stock Redeemed Or Called During Period Value 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001333986-25-000020 20240331 Stock Repurchased And Retired During Period Value 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001333986-25-000020 20240331 Treasury Stock Value Acquired Cost Method 251000000.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001333986-25-000020 20250331 Treasury Stock Value Acquired Cost Method 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001333986-25-000020 20250331 Treasury Stock Value Acquired Cost Method 0.0000 USD 1 us-gaap/2024 Equity Components= Preferred Stock Including Additional Paid In Capital;
0001333986-25-000020 20231231 Weighted Average Number Of Diluted Shares Outstanding 0.0000 shares 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Weighted Average Number Of Diluted Shares Outstanding 327300000.0000 shares 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Weighted Average Number Of Diluted Shares Outstanding 330400000.0000 shares 2 us-gaap/2024
0001333986-25-000020 20241231 Weighted Average Number Of Diluted Shares Outstanding 0.0000 shares 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20221231 Weighted Average Number Of Shares Outstanding Basic 377600000.0000 shares 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Weighted Average Number Of Shares Outstanding Basic 355200000.0000 shares 1 us-gaap/2024
0001333986-25-000020 20230930 Weighted Average Number Of Shares Outstanding Basic 0.0000 shares 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Weighted Average Number Of Shares Outstanding Basic 354400000.0000 shares 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20231231 Weighted Average Number Of Shares Outstanding Basic 350100000.0000 shares 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Weighted Average Number Of Shares Outstanding Basic 330200000.0000 shares 1 us-gaap/2024
0001333986-25-000020 20240930 Weighted Average Number Of Shares Outstanding Basic 318200000.0000 shares 1 us-gaap/2024
0001333986-25-000020 20241231 Separate Account Assets 0.0000 USD 0 us-gaap/2024 Product Or Service= Legacy Segment; Separate Account Asset Category= Separate Account Common Stock;
0001333986-25-000020 20241231 Separate Account Assets 18828000000.0000 USD 0 us-gaap/2024 Product Or Service= Protection Solutions;
0001333986-25-000020 20250331 Separate Account Assets 1000000.0000 USD 0 us-gaap/2024 Product Or Service= Individual Retirement; Separate Account Asset Category= Separate Account Debt Security;
0001333986-25-000020 20250331 Separate Account Assets 1133000000.0000 USD 0 us-gaap/2024 Separate Account Asset Category= Separate Account Bonds And Notes;
0001333986-25-000020 20240331 Separate Accounts Liability 4706000000.0000 USD 0 us-gaap/2024 Business Segments= Group Retirement; Product Or Service= Momentum;
0001333986-25-000020 20241231 Separate Accounts Liability 4813000000.0000 USD 0 us-gaap/2024 Business Segments= Group Retirement; Product Or Service= Momentum;
0001333986-25-000020 20241231 Separate Accounts Liability 12055000000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001333986-25-000020 20250331 Separate Accounts Liability 124569000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20250331 Separate Accounts Liability 4637000000.0000 USD 0 us-gaap/2024 Business Segments= Group Retirement; Product Or Service= Momentum;
0001333986-25-000020 20250331 Separate Accounts Liability 4720000000.0000 USD 0 us-gaap/2024 Business Segments= Individual Retirement; Product Or Service= Investment Edge;
0001333986-25-000020 20250331 Separate Accounts Liability 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001333986-25-000020 20231231 Stockholders Equity 2636000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240930 Stockholders Equity 3220000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 27000000.0000 USD 0 us-gaap/2024 Equity Components= Parent; Restatement= Restatement Adjustment;
0001333986-25-000020 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1401000000.0000 USD 0 us-gaap/2024 Equity Components= Parent; Restatement= Scenario Previously Reported;
0001333986-25-000020 20230331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 21000000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 22000000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1587000000.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0001333986-25-000020 20230930 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 11169000000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001333986-25-000020 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2636000000.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0001333986-25-000020 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 7000000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2032000000.0000 USD 0 us-gaap/2024 Equity Components= Parent; Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1598000000.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0001333986-25-000020 20240930 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -6000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -19000000.0000 USD 0 us-gaap/2024 Equity Components= Parent; Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 71000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss; Net Unrealized Investment Gains Losses= Policyholders Liabilities; Unrealized Investment Gains Losses With O T T I And All Other= Unrealized Investment Gains Losses All Other;
0001333986-25-000020 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -8754000000.0000 USD 0 us-gaap/2024 Equity Components= Aoci Including Portion Attributable To Noncontrolling Interest;
0001333986-25-000020 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1585000000.0000 USD 0 us-gaap/2024 Equity Components= Parent; Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 10647000000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Scenario Previously Reported;
0001333986-25-000020 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 293000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Gain Loss Financial Liability Liability For Future Policy Benefit Including Portion Attributable To Noncontrolling Interest;
0001333986-25-000020 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 279000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss; Net Unrealized Investment Gains Losses= Deferred Income Tax Asset Liability; Unrealized Investment Gains Losses With O T T I And All Other= Unrealized Investment Gains Losses All Other;
0001333986-25-000020 20240331 Stockholders Equity Other 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001333986-25-000020 20250331 Stockholders Equity Other 43000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20250331 Stockholders Equity Other -1000000.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001333986-25-000020 20240331 Stock Issued During Period Value Treasury Stock Reissued 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001333986-25-000020 20250331 Stock Issued During Period Value Treasury Stock Reissued 20000000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001333986-25-000020 20250331 Stock Repurchased And Retired During Period Value 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001333986-25-000020 20250331 Stock Repurchased And Retired During Period Value 0.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001333986-25-000020 20240930 Trading Securities Debt 2215000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Treasury Stock Value Acquired Cost Method 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001333986-25-000020 20240331 Treasury Stock Value Acquired Cost Method 2000000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001333986-25-000020 20250331 Treasury Stock Value Acquired Cost Method 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001333986-25-000020 20221231 Weighted Average Number Of Diluted Shares Outstanding 379900000.0000 shares 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Weighted Average Number Of Diluted Shares Outstanding 318200000.0000 shares 1 us-gaap/2024
0001333986-25-000020 20240930 Weighted Average Number Of Diluted Shares Outstanding 318200000.0000 shares 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20250331 Weighted Average Number Of Diluted Shares Outstanding 311900000.0000 shares 1 us-gaap/2024
0001333986-25-000020 20221231 Weighted Average Number Of Shares Outstanding Basic 0.0000 shares 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Weighted Average Number Of Shares Outstanding Basic 355200000.0000 shares 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20231231 Weighted Average Number Of Shares Outstanding Basic 0.0000 shares 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Weighted Average Number Of Shares Outstanding Basic 318200000.0000 shares 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Weighted Average Number Of Shares Outstanding Basic 321200000.0000 shares 4 us-gaap/2024
0001333986-25-000020 20231231 Accumulated Other Comprehensive Income Loss Net Of Tax -20000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Accumulated Other Comprehensive Income Loss Net Of Tax -8645000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Accumulated Other Comprehensive Income Loss Net Of Tax -6601000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20250331 Additional Paid In Capital 2305000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 16000000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001333986-25-000020 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Preferred Stock Including Additional Paid In Capital;
0001333986-25-000020 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 8000000.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001333986-25-000020 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 42000000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001333986-25-000020 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Preferred Stock Including Additional Paid In Capital;
0001333986-25-000020 20240630 Assets -130000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Assets 287769000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Assets 41583000000.0000 USD 0 us-gaap/2024 Business Segments= Protection Solutions; Consolidation Items= Operating Segments;
0001333986-25-000020 20250331 Assets 34955000000.0000 USD 0 us-gaap/2024 Business Segments= Legacy; Consolidation Items= Operating Segments;
0001333986-25-000020 20250331 Assets 41725000000.0000 USD 0 us-gaap/2024 Business Segments= Protection Solutions; Consolidation Items= Operating Segments;
0001333986-25-000020 20230630 Benefits Losses And Expenses -14000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Benefits Losses And Expenses 19000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Benefits Losses And Expenses 2011000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20250331 Commitments And Contingencies USD 0 us-gaap/2024 See Note 16 of the Notes to these Consolidated Financial Statements for details of commitments and contingent liabilities.
0001333986-25-000020 20241231 Common Stock Shares Outstanding 309900248.0000 shares 0 us-gaap/2024
0001333986-25-000020 20250331 Common Stock Shares Outstanding 306340799.0000 shares 0 us-gaap/2024
0001333986-25-000020 20241231 Common Stock Value 5000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20231231 Comprehensive Income Net Of Tax 2517000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Comprehensive Income Net Of Tax -302000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230930 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 64000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230930 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 0.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20231231 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 351000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 0.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 407000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20221231 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest -7917000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 208000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 2952000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20231231 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest -40000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest -6000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 89000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 2000000.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001333986-25-000020 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= Redeemable Preferred Stock;
0001333986-25-000020 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 7000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= Residential Mortgage Backed Securities;
0001333986-25-000020 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 54248000000.0000 USD 0 us-gaap/2024 Financial Instrument= Corporate Debt Securities;
0001333986-25-000020 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 54000000.0000 USD 0 us-gaap/2024 Financial Instrument= Redeemable Preferred Stock;
0001333986-25-000020 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Commercial Mortgage Backed Securities;
0001333986-25-000020 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Government Debt Securities;
0001333986-25-000020 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Public Corporate;
0001333986-25-000020 20241231 Debt Securities Available For Sale Excluding Accrued Interest 3913000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Commercial Mortgage Backed Securities;
0001333986-25-000020 20241231 Debt Securities Available For Sale Excluding Accrued Interest 232000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Asset Backed Securities;
0001333986-25-000020 20241231 Debt Securities Available For Sale Excluding Accrued Interest 59000000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Redeemable Preferred Stock;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 75510000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 47106000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Public Corporate;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 4754000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Residential Mortgage Backed Securities;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 389000000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001333986-25-000020 20240331 Deferred Income Tax Assets Net 2075000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240630 Deferred Income Tax Assets Net 2129000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240630 Deferred Income Tax Assets Net 2117000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Deferred Income Tax Assets Net 1707000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240930 Deferred Income Tax Assets Net 6000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Deferred Policy Acquisition Cost Amortization Expense Net Investment Gains Losses 2000000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001333986-25-000020 20250331 Deferred Policy Acquisition Cost Amortization Expense Net Investment Gains Losses 2000000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001333986-25-000020 20231231 Deferred Policy Acquisition Costs 116000000.0000 USD 0 us-gaap/2024 Business Segments= Corporate And Other; Product Or Service= Closed Block;
0001333986-25-000020 20231231 Deferred Policy Acquisition Costs 172000000.0000 USD 0 us-gaap/2024 Business Segments= Individual Retirement; Product Or Service= Investment Edge;
0001333986-25-000020 20241231 Deferred Policy Acquisition Costs 7150000000.0000 USD 0 us-gaap/2024 Business Segments= Corporate;
0001333986-25-000020 20241231 Deferred Policy Acquisition Costs 154000000.0000 USD 0 us-gaap/2024 Business Segments= Individual Retirement; Product Or Service= E Q U I V E S T Individual;
0001333986-25-000020 20250331 Deferred Policy Acquisition Costs 307000000.0000 USD 0 us-gaap/2024 Business Segments= Protection Solutions; Product Or Service= Term;
0001333986-25-000020 20240331 Derivative Gain Loss On Derivative Net -1000000.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Credit Default Swap; Hedging Designation= Nondesignated;
0001333986-25-000020 20240331 Derivative Gain Loss On Derivative Net 1000000.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Currency Foward; Hedging Designation= Nondesignated;
0001333986-25-000020 20240331 Derivative Gain Loss On Derivative Net -3136000000.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Hedging Designation= Nondesignated;
0001333986-25-000020 20240331 Derivative Gain Loss On Derivative Net -164000000.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Interest Rate Swap; Hedging Designation= Nondesignated;
0001333986-25-000020 20240331 Derivative Gain Loss On Derivative Net 2795000000.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Stock Option; Hedging Designation= Nondesignated;
0001333986-25-000020 20240331 Derivative Gain Loss On Derivative Net 0.0000 USD 1 us-gaap/2024 Derivative Instruments Gain Loss By Hedging Relationship= Cash Flow Hedging; Hedging Designation= Designated As Hedging Instrument;
0001333986-25-000020 20250331 Derivative Gain Loss On Derivative Net 0.0000 USD 1 us-gaap/2024 Derivative Instruments Gain Loss By Hedging Relationship= Cash Flow Hedging; Hedging Designation= Designated As Hedging Instrument;
0001333986-25-000020 20240331 Dividends Common Stock 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001333986-25-000020 20250331 Dividends Common Stock 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001333986-25-000020 20240331 Dividends Preferred Stock 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001333986-25-000020 20250331 Dividends Preferred Stock 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001333986-25-000020 20250331 Dividends Preferred Stock 14000000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001333986-25-000020 20230630 Earnings Per Share Basic 0.0100 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Earnings Per Share Basic 2.4900 USD 2 us-gaap/2024
0001333986-25-000020 20230630 Earnings Per Share Basic 2.5000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230930 Earnings Per Share Basic 5.4900 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Earnings Per Share Basic 0.2400 USD 1 us-gaap/2024
0001333986-25-000020 20240630 Earnings Per Share Basic 1.4700 USD 2 us-gaap/2024
0001333986-25-000020 20240930 Earnings Per Share Basic -0.4600 USD 1 us-gaap/2024
0001333986-25-000020 20241231 Earnings Per Share Basic -0.0800 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Earnings Per Share Basic 3.8200 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20221231 Earnings Per Share Diluted 5.4200 USD 4 us-gaap/2024
0001333986-25-000020 20230630 Earnings Per Share Diluted 2.4900 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Earnings Per Share Diluted 0.3000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Earnings Per Share Diluted 1.2300 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 288000000.0000 USD 0 us-gaap/2024 Financing Receivable Recorded Investment By Class Of Financing Receivable= Commercial Loan;
0001333986-25-000020 20240331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 3000000.0000 USD 0 us-gaap/2024 Financing Receivable Recorded Investment By Class Of Financing Receivable= Residential Mortgage;
0001333986-25-000020 20250331 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 254000000.0000 USD 0 us-gaap/2024 Financing Receivable Recorded Investment By Class Of Financing Receivable= Commercial Loan;
0001333986-25-000020 20241231 Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss 20072000000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure;
0001333986-25-000020 20250331 Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001333986-25-000020 20240331 Gain Loss On Other Investments Net -19000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20230930 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 1455000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230930 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -26000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 681000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 900000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20240930 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -14000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -25000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Income Tax Expense Benefit -2000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Income Tax Expense Benefit 340000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Income Tax Expense Benefit 140000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20240930 Income Tax Expense Benefit -5000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20221231 Increase Decrease In Accrued Income Taxes Payable 470000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Increase Decrease In Accrued Income Taxes Payable 155000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Increase Decrease In Accrued Income Taxes Payable 322000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20250331 Increase Decrease In Accrued Income Taxes Payable 6000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240331 Increase Decrease In Bank Overdrafts 46000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20240331 Increase Decrease In Cash And Securities Segregated Under Federal And Other Regulations -2000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20230930 Increase Decrease In Future Policy Benefit Reserves 197000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20231231 Increase Decrease In Future Policy Benefit Reserves 329000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20240331 Increase Decrease In Reinsurance Recoverable 2000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Increase Decrease In Reinsurance Recoverable 626000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Increase Decrease In Reinsurance Recoverable 2000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20250331 Insurance Commissions 293000000.0000 USD 1 us-gaap/2024 Business Segments= Wealth Management; Consolidation Items= Operating Segments;
0001333986-25-000020 20230630 Interest Credited To Policyholders Account Balances -3000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Interest Credited To Policyholders Account Balances -16000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Interest Credited To Policyholders Account Balances -4000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Interest Credited To Policyholders Account Balances 1520000000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Interest Credited To Policyholders Account Balances 3220000000.0000 USD 1 us-gaap/2024 Business Segments= Individual Retirement; Product Or Service= S C S;
0001333986-25-000020 20240331 Interest Credited To Policyholders Account Balances 47000000.0000 USD 1 us-gaap/2024 Business Segments= Protection Solutions; Product Or Service= Variable Universal Life;
0001333986-25-000020 20241231 Interest Credited To Policyholders Account Balances -6000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20250331 Interest Credited To Policyholders Account Balances 3000000.0000 USD 1 us-gaap/2024 Business Segments= Group Retirement; Product Or Service= Momentum;
0001333986-25-000020 20250331 Interest Credited To Policyholders Account Balances 14000000.0000 USD 1 us-gaap/2024 Business Segments= Individual Retirement; Product Or Service= E Q U I V E S T Individual;
0001333986-25-000020 20250331 Investment In Capitalized Software Leasehold Improvements And E D P Equipment 10000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20240630 Investment Management And Service Fees 1240000000.0000 USD 1 0001333986-25-000020 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Investments 114246000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Investments 128000000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary; Underlying Asset Class= Collateralized Loan Obligations;
0001333986-25-000020 20250331 Investments 3100000000.0000 USD 0 us-gaap/2024 Consolidated Entities= Non Consolidated Vairable Interest Entities V I E;
0001333986-25-000020 20241231 Investments Fixed Maturities Fair Value Option Variable Interest Entity 0.0000 USD 0 0001333986-25-000020 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001333986-25-000020 20230630 Labor And Related Expense -1000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Labor And Related Expense -5000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Labor And Related Expense 2451000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20250331 Liabilities 282872000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20231231 Liabilities And Stockholders Equity 276695000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20231231 Liabilities And Stockholders Equity -119000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Liabilities And Stockholders Equity 285469000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20241231 Liabilities And Stockholders Equity -139000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Liability For Future Policy Benefit Remeasurement Gain Loss -83000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230930 Liability For Future Policy Benefit Remeasurement Gain Loss -46000000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Liability For Future Policy Benefit Remeasurement Gain Loss -9000000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Liability For Future Policy Benefit Remeasurement Gain Loss -6000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20250331 Liability For Future Policy Benefit Remeasurement Gain Loss 2000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240331 Liability For Future Policy Benefits 1316000000.0000 USD 0 us-gaap/2024 Business Segments= Protection Solutions; Consolidation Items= Operating Segments; Product Or Service= Term;
0001333986-25-000020 20240331 Liability For Future Policy Benefits 16000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Liability For Future Policy Benefits 5204000000.0000 USD 0 us-gaap/2024 Product Or Service= Whole Life Closed Block And Open Block Products;
0001333986-25-000020 20250331 Liability For Future Policy Benefits 4782000000.0000 USD 0 us-gaap/2024 Product Or Service= Payout;
0001333986-25-000020 20250331 Liability For Future Policy Benefits 1264000000.0000 USD 0 us-gaap/2024 Product Or Service= Universal Life;
0001333986-25-000020 20250331 Loans Insurance Policy 4318000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20250331 Loans Insurance Policy 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001333986-25-000020 20240331 Market Risk Benefit Asset Amount 821000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240630 Market Risk Benefit Asset Amount 799000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240630 Market Risk Benefit Asset Amount 803000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20221231 Market Risk Benefit Change In Fair Value Gain Loss 1233000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20230630 Market Risk Benefit Change In Fair Value Gain Loss 955000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230930 Market Risk Benefit Change In Fair Value Gain Loss 1764000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20240630 Market Risk Benefit Change In Fair Value Gain Loss -1000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Market Risk Benefit Change In Fair Value Gain Loss -31000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Market Risk Benefit Liability Amount 12612000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20250331 Market Risk Benefit Liability Amount 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001333986-25-000020 20231231 Minority Interest 0.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Minority Interest 1858000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001333986-25-000020 20240331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001333986-25-000020 20250331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001333986-25-000020 20240331 Net Cash Provided By Used In Financing Activities 4945000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20231231 Net Cash Provided By Used In Operating Activities 0.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Net Income Loss 932000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20231231 Net Income Loss -19000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Net Income Loss -134000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Net Income Loss Attributable To Noncontrolling Interest 161000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20231231 Net Income Loss Attributable To Noncontrolling Interest 341000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20240331 Net Income Loss Attributable To Noncontrolling Interest 103000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Net Income Loss Attributable To Noncontrolling Interest 516000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20231231 Net Income Loss Available To Common Stockholders Basic -19000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Net Income Loss Available To Common Stockholders Diluted 1034000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240331 Net Income Loss Available To Common Stockholders Diluted -22000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Net Income Loss Available To Common Stockholders Diluted 0.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Net Income Loss Available To Common Stockholders Diluted -146000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230630 Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest -4000000.0000 USD 2 0001333986-25-000020 Equity Components= Retained Earnings; Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest 1980000000.0000 USD 3 0001333986-25-000020 Equity Components= Retained Earnings;
0001333986-25-000020 20240331 Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest 85000000.0000 USD 1 0001333986-25-000020 Equity Components= Noncontrolling Interest;
0001333986-25-000020 20240331 Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest 0.0000 USD 1 0001333986-25-000020 Equity Components= Preferred Stock Including Additional Paid In Capital;
0001333986-25-000020 20240331 Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest 114000000.0000 USD 1 0001333986-25-000020 Equity Components= Retained Earnings; Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest 0.0000 USD 1 0001333986-25-000020 Equity Components= Treasury Stock Common;
0001333986-25-000020 20240930 Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest 388000000.0000 USD 3 0001333986-25-000020 Equity Components= Retained Earnings;
0001333986-25-000020 20240930 Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest -20000000.0000 USD 3 0001333986-25-000020 Equity Components= Retained Earnings; Restatement= Restatement Adjustment;
0001333986-25-000020 20250331 Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest 0.0000 USD 1 0001333986-25-000020 Equity Components= Preferred Stock Including Additional Paid In Capital;
0001333986-25-000020 20250331 Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest 0.0000 USD 1 0001333986-25-000020 Equity Components= Treasury Stock Common;
0001333986-25-000020 20240630 Other Assets 3000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20221231 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax1 -12570000000.0000 USD 4 0001333986-25-000020
0001333986-25-000020 20240630 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax1 -922000000.0000 USD 2 0001333986-25-000020
0001333986-25-000020 20240630 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax1 -921000000.0000 USD 2 0001333986-25-000020 Restatement= Scenario Previously Reported;
0001333986-25-000020 20221231 Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk -1272000000.0000 USD 4 0001333986-25-000020
0001333986-25-000020 20231231 Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk 22000000.0000 USD 4 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk 5000000.0000 USD 1 0001333986-25-000020 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk 389000000.0000 USD 4 0001333986-25-000020 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Other Comprehensive Income Loss Net Of Tax -627000000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001333986-25-000020 20230630 Other Comprehensive Income Loss Net Of Tax -1000000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Other Comprehensive Income Loss Net Of Tax -2705000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230930 Other Comprehensive Income Loss Net Of Tax -38000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Other Comprehensive Income Loss Net Of Tax -874000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20231231 Revenues -68000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Other Cost And Expense Operating 450000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20231231 Revenues 10460000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20231231 Other Comprehensive Income Loss Net Of Tax 1225000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Other Comprehensive Income Loss Net Of Tax -482000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240630 Other Comprehensive Income Loss Net Of Tax -868000000.0000 USD 2 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001333986-25-000020 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 19000000.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001333986-25-000020 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001333986-25-000020 20231231 Assets 276695000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240331 Assets -108000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Assets 295727000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20241231 Assets 295866000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20250331 Assets 309000000.0000 USD 0 us-gaap/2024 Consolidated Entities= Consolidated Entity; Equity Method Investment Nonconsolidated Investee= A B Sponsored Investment Funds;
0001333986-25-000020 20250331 Assets 371700000000.0000 USD 0 us-gaap/2024 Consolidated Entities= Non Consolidated Vairable Interest Entities V I E;
0001333986-25-000020 20230630 Benefits Losses And Expenses 4644000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20240930 Benefits Losses And Expenses -6000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Benefits Losses And Expenses 23000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Common Stock Dividends Per Share Declared 0.2200 USD 1 us-gaap/2024
0001333986-25-000020 20221231 Comprehensive Income Net Of Tax -8096000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20230630 Comprehensive Income Net Of Tax 132000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230930 Comprehensive Income Net Of Tax -54000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20231231 Comprehensive Income Net Of Tax 2477000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20240630 Comprehensive Income Net Of Tax -51000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20221231 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 225000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20230630 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 166000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20230630 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 166000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 0.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 168000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20241231 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 514000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20221231 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest -7871000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20230630 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 2924000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20230930 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest -82000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest -33000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 1997000000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Credit And Intent To Sell Losses On Available For Sale Debt Securities And Loans 20000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= Foreign Government Debt Securities;
0001333986-25-000020 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= Redeemable Preferred Stock;
0001333986-25-000020 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= U S States And Political Subdivisions;
0001333986-25-000020 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 84717000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 13660000000.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities;
0001333986-25-000020 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 689000000.0000 USD 0 us-gaap/2024 Financial Instrument= Foreign Government Debt Securities;
0001333986-25-000020 20241231 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 472000000.0000 USD 0 us-gaap/2024 Financial Instrument= U S States And Political Subdivisions;
0001333986-25-000020 20250331 Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss 4485000000.0000 USD 0 us-gaap/2024 Financial Instrument= Commercial Mortgage Backed Securities;
0001333986-25-000020 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001333986-25-000020 20241231 Debt Securities Available For Sale Excluding Accrued Interest 386000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001333986-25-000020 20241231 Debt Securities Available For Sale Excluding Accrued Interest 2712000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001333986-25-000020 20241231 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001333986-25-000020 20241231 Debt Securities Available For Sale Excluding Accrued Interest 4383000000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Residential Mortgage Backed Securities;
0001333986-25-000020 20241231 Debt Securities Available For Sale Excluding Accrued Interest 13699000000.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S States And Political Subdivisions;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 559000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Foreign Government Debt Securities;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 57000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Redeemable Preferred Stock;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 2487000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 559000000.0000 USD 0 us-gaap/2024 Financial Instrument= Foreign Government Debt Securities;
0001333986-25-000020 20240630 Deferred Income Tax Assets Net 12000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Deferred Policy Acquisition Cost Amortization Expense Net Investment Gains Losses 109000000.0000 USD 1 us-gaap/2024 Business Segments= Individual Retirement; Consolidation Items= Operating Segments;
0001333986-25-000020 20250331 Deferred Policy Acquisition Cost Amortization Expense Net Investment Gains Losses 0.0000 USD 1 us-gaap/2024 Business Segments= Asset Management; Consolidation Items= Operating Segments;
0001333986-25-000020 20250331 Deferred Policy Acquisition Cost Amortization Expense Net Investment Gains Losses 124000000.0000 USD 1 us-gaap/2024 Business Segments= Individual Retirement; Consolidation Items= Operating Segments;
0001333986-25-000020 20240331 Deferred Policy Acquisition Costs 1009000000.0000 USD 0 us-gaap/2024 Business Segments= Protection Solutions; Product Or Service= Variable Universal Life;
0001333986-25-000020 20241231 Deferred Policy Acquisition Costs 225000000.0000 USD 0 us-gaap/2024 Business Segments= Individual Retirement; Product Or Service= Investment Edge;
0001333986-25-000020 20241231 Deferred Policy Acquisition Costs 1938000000.0000 USD 0 us-gaap/2024 Business Segments= Individual Retirement; Product Or Service= Structured Capital Strategies;
0001333986-25-000020 20250331 Deferred Policy Acquisition Costs 2018000000.0000 USD 0 us-gaap/2024 Business Segments= Individual Retirement; Product Or Service= Structured Capital Strategies;
0001333986-25-000020 20250331 Deferred Policy Acquisition Costs 186000000.0000 USD 0 us-gaap/2024 Business Segments= Protection Solutions; Product Or Service= Indexed Universal Life;
0001333986-25-000020 20250331 Deferred Policy Acquisition Costs 172000000.0000 USD 0 us-gaap/2024 Business Segments= Protection Solutions; Product Or Service= Universal Life;
0001333986-25-000020 20240331 Derivative Gain Loss On Derivative Net 0.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Currency Swap; Derivative Instruments Gain Loss By Hedging Relationship= Cash Flow Hedging; Hedging Designation= Designated As Hedging Instrument;
0001333986-25-000020 20240331 Derivative Gain Loss On Derivative Net 12000000.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Currency Swap; Hedging Designation= Nondesignated;
0001333986-25-000020 20240331 Derivative Gain Loss On Derivative Net 0.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Interest Rate Option; Hedging Designation= Nondesignated;
0001333986-25-000020 20250331 Derivative Gain Loss On Derivative Net -30000000.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Currency Swap; Hedging Designation= Nondesignated;
0001333986-25-000020 20250331 Derivative Gain Loss On Derivative Net -2645000000.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Stock Option; Hedging Designation= Nondesignated;
0001333986-25-000020 20240331 Dividends Common Stock 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001333986-25-000020 20240331 Dividends Preferred Stock 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001333986-25-000020 20250331 Dividends Preferred Stock 14000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20250331 Dividends Preferred Stock 0.0000 USD 1 us-gaap/2024 Equity Components= Preferred Stock Including Additional Paid In Capital;
0001333986-25-000020 20230630 Earnings Per Share Basic 2.0600 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Earnings Per Share Basic -0.0100 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Earnings Per Share Basic -0.0500 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Earnings Per Share Basic 1.5300 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Earnings Per Share Basic 0.0100 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Earnings Per Share Basic 1.0300 USD 3 us-gaap/2024
0001333986-25-000020 20230930 Earnings Per Share Diluted 5.4100 USD 3 us-gaap/2024
0001333986-25-000020 20230930 Earnings Per Share Diluted 5.4700 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20231231 Earnings Per Share Diluted 3.4200 USD 4 us-gaap/2024
0001333986-25-000020 20240630 Earnings Per Share Diluted 1.4500 USD 2 us-gaap/2024
0001333986-25-000020 20241231 Earnings Per Share Diluted 3.6900 USD 4 us-gaap/2024
0001333986-25-000020 20250331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 13000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20231231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 272000000.0000 USD 0 us-gaap/2024 Financing Receivable Recorded Investment By Class Of Financing Receivable= Commercial Loan;
0001333986-25-000020 20241231 Financing Receivable Allowance For Credit Loss Excluding Accrued Interest 15000000.0000 USD 0 us-gaap/2024 Financing Receivable Recorded Investment By Class Of Financing Receivable= Agricultural Mortgage Loans;
0001333986-25-000020 20241231 Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss 18567000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001333986-25-000020 20250331 Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss 19353000000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001333986-25-000020 20250331 Gain Loss On Investments -14000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240331 Gains Loss On Investments And Disposition Of Business -26000000.0000 USD 1 0001333986-25-000020 Investment Type= Fixed Maturities;
0001333986-25-000020 20250331 Gains Loss On Investments And Disposition Of Business -7000000.0000 USD 1 0001333986-25-000020 Investment Type= Mortgages;
0001333986-25-000020 20250331 Income Loss Due To Novation In Pre Tax Net Income -499000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20221231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 2975000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20240930 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 3000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 914000000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Income Tax Expense Benefit -293000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20231231 Increase Decrease In Accrued Income Taxes Payable -5000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20231231 Increase Decrease In Accrued Income Taxes Payable -1163000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Increase Decrease In Accrued Income Taxes Payable 181000000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20231231 Increase Decrease In Future Policy Benefit Reserves 0.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Insurance Commissions 260000000.0000 USD 1 us-gaap/2024 Business Segments= Wealth Management; Consolidation Items= Operating Segments;
0001333986-25-000020 20240331 Insurance Commissions 3000000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001333986-25-000020 20250331 Insurance Commissions 42000000.0000 USD 1 us-gaap/2024 Business Segments= Protection Solutions; Consolidation Items= Operating Segments;
0001333986-25-000020 20221231 Interest Credited To Policyholders Account Balances 1415000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20221231 Interest Credited To Policyholders Account Balances 1410000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230930 Interest Credited To Policyholders Account Balances 556000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Interest Credited To Policyholders Account Balances 17000000.0000 USD 1 us-gaap/2024 Business Segments= Individual Retirement; Product Or Service= E Q U I V E S T Individual;
0001333986-25-000020 20240930 Interest Credited To Policyholders Account Balances 1879000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20240630 Investment Management And Service Fees 2518000000.0000 USD 2 0001333986-25-000020
0001333986-25-000020 20240930 Investments 0.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Investments 3000000000.0000 USD 0 us-gaap/2024 Consolidated Entities= Non Consolidated Vairable Interest Entities V I E;
0001333986-25-000020 20250331 Investments Fixed Maturities Fair Value Option Variable Interest Entity 1842000000.0000 USD 0 0001333986-25-000020 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001333986-25-000020 20230930 Labor And Related Expense 1742000000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20231231 Labor And Related Expense -5000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Liabilities 280831000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Liabilities 283212000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20250331 Liabilities 3000000.0000 USD 0 us-gaap/2024 Consolidated Entities= Consolidated Entity Excluding Vie; Equity Method Investment Nonconsolidated Investee= A B Sponsored Investment Funds;
0001333986-25-000020 20240630 Liabilities And Stockholders Equity 287639000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20230930 Liability For Future Policy Benefit Remeasurement Gain Loss -80000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20240331 Liability For Future Policy Benefit Remeasurement Gain Loss -5000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240630 Liability For Future Policy Benefit Remeasurement Gain Loss 2000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20240630 Liability For Future Policy Benefit Remeasurement Gain Loss -5000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Liability For Future Policy Benefit Remeasurement Gain Loss 6000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20250331 Liability For Future Policy Benefit Remeasurement Gain Loss 458000000.0000 USD 1 us-gaap/2024 Product Or Service= Novation;
0001333986-25-000020 20241231 Liability For Future Policy Benefits 15508000000.0000 USD 0 us-gaap/2024 Product Or Service= All Future Policyholder Benefits;
0001333986-25-000020 20241231 Liability For Future Policy Benefits 1246000000.0000 USD 0 us-gaap/2024 Product Or Service= Universal Life;
0001333986-25-000020 20250331 Liability For Future Policy Benefits 17372000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20250331 Liability For Future Policy Benefits 454000000.0000 USD 0 us-gaap/2024 Consolidation Items= Corporate Non Segment; Product Or Service= Group Pension;
0001333986-25-000020 20250331 Liability For Future Policy Benefits 1353000000.0000 USD 0 us-gaap/2024 Consolidation Items= Corporate Non Segment; Product Or Service= Health;
0001333986-25-000020 20241231 Long Term Debt Noncurrent 3833000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20250331 Long Term Debt Noncurrent 4330000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20231231 Market Risk Benefit Asset Amount 3000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Market Risk Benefit Change In Fair Value Gain Loss -8000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Market Risk Benefit Change In Fair Value Gain Loss 1123000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20250331 Market Risk Benefit Change In Fair Value Gain Loss -672000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20231231 Market Risk Benefit Liability Amount 14612000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Market Risk Benefit Liability Amount 12814000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Market Risk Benefit Liability Amount 11810000000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001333986-25-000020 20240930 Minority Interest 0.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20250331 Minority Interest 1804000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20250331 Minority Interest Decrease From Redemptions 30000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20250331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001333986-25-000020 20250331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001333986-25-000020 20230630 Net Cash Provided By Used In Operating Activities 0.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20231231 Net Cash Provided By Used In Operating Activities -208000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20240331 Net Cash Provided By Used In Operating Activities 0.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20250331 Net Cash Provided By Used In Operating Activities 158000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230930 Net Income Loss -20000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Net Income Loss 542000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Net Income Loss -20000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20250331 Net Income Loss 63000000.0000 USD 1 us-gaap/2024 Consolidation Items= Material Reconciling Items;
0001333986-25-000020 20230930 Net Income Loss Attributable To Noncontrolling Interest 232000000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Net Income Loss Attributable To Noncontrolling Interest 0.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Net Income Loss Attributable To Noncontrolling Interest 0.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Net Income Loss Attributable To Noncontrolling Interest 516000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20231231 Net Income Loss Available To Common Stockholders Basic 1222000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Net Income Loss Available To Common Stockholders Basic -22000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Net Income Loss Available To Common Stockholders Basic -20000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20250331 Net Income Loss Available To Common Stockholders Basic 49000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230630 Net Income Loss Available To Common Stockholders Diluted 896000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230930 Net Income Loss Available To Common Stockholders Diluted 1050000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230930 Net Income Loss Available To Common Stockholders Diluted 1946000000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20231231 Net Income Loss Available To Common Stockholders Diluted -19000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20231231 Net Income Loss Available To Common Stockholders Diluted 1222000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Net Income Loss Available To Common Stockholders Diluted -22000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Net Income Loss Available To Common Stockholders Diluted 334000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20230930 Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest -16000000.0000 USD 1 0001333986-25-000020 Equity Components= Retained Earnings; Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Stock Repurchased And Retired During Period Value 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001333986-25-000020 20240930 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 4956000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240930 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 9964000000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001333986-25-000020 20240930 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 9977000000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings; Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -19000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 372000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Gain Loss Financial Liability Liability For Future Policy Benefit Including Portion Attributable To Noncontrolling Interest;
0001333986-25-000020 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -20000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -6881000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Net Unrealized Investment Gain Loss; Net Unrealized Investment Gains Losses= A O C I Gains Losses Related To Net Unrealized Investment Gains Losses; Unrealized Investment Gains Losses With O T T I And All Other= Unrealized Investment Gains Losses All Other;
0001333986-25-000020 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2401000000.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0001333986-25-000020 20240331 Stockholders Equity Other 21000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20250331 Stockholders Equity Other 44000000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001333986-25-000020 20250331 Stockholders Equity Other 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001333986-25-000020 20240331 Stock Issued During Period Value Treasury Stock Reissued 17000000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001333986-25-000020 20250331 Stock Issued During Period Value Treasury Stock Reissued 20000000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001333986-25-000020 20250331 Stock Redeemed Or Called During Period Value 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001333986-25-000020 20240331 Stock Repurchased And Retired During Period Value 0.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001333986-25-000020 20240331 Stock Repurchased And Retired During Period Value 143000000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001333986-25-000020 20250331 Stock Repurchased And Retired During Period Value 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001333986-25-000020 20250331 Stock Repurchased And Retired During Period Value 0.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001333986-25-000020 20240930 Trading Securities Debt 2215000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20221231 Weighted Average Number Of Diluted Shares Outstanding 379900000.0000 shares 4 us-gaap/2024
0001333986-25-000020 20230630 Weighted Average Number Of Diluted Shares Outstanding 360000000.0000 shares 2 us-gaap/2024
0001333986-25-000020 20230930 Weighted Average Number Of Diluted Shares Outstanding 348000000.0000 shares 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20231231 Weighted Average Number Of Diluted Shares Outstanding 351600000.0000 shares 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Weighted Average Number Of Diluted Shares Outstanding 0.0000 shares 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Weighted Average Number Of Diluted Shares Outstanding 324800000.0000 shares 4 us-gaap/2024
0001333986-25-000020 20221231 Weighted Average Number Of Shares Outstanding Basic 377600000.0000 shares 4 us-gaap/2024
0001333986-25-000020 20230930 Weighted Average Number Of Shares Outstanding Basic 346400000.0000 shares 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Weighted Average Number Of Shares Outstanding Basic 327200000.0000 shares 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Weighted Average Number Of Shares Outstanding Basic 324200000.0000 shares 3 us-gaap/2024
0001333986-25-000020 20240630 Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest -22000000.0000 USD 2 0001333986-25-000020 Equity Components= Retained Earnings; Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest 1307000000.0000 USD 4 0001333986-25-000020 Equity Components= Retained Earnings; Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Notes Issued By Consolidated Variable Interest Entity Fair Value Option 1933000000.0000 USD 0 0001333986-25-000020 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001333986-25-000020 20230630 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax1 -620000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20230630 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax1 4000000.0000 USD 1 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax1 -409000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20240630 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax1 -1000000.0000 USD 2 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax1 1334000000.0000 USD 3 0001333986-25-000020
0001333986-25-000020 20230630 Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk 92000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20230630 Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk -14000000.0000 USD 2 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk 8000000.0000 USD 3 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk -20000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20240331 Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk 5000000.0000 USD 1 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk 133000000.0000 USD 3 0001333986-25-000020 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk 375000000.0000 USD 4 0001333986-25-000020
0001333986-25-000020 20241231 Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk -14000000.0000 USD 4 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Other Comprehensive Income Loss Net Of Tax -626000000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Other Comprehensive Income Loss Net Of Tax 1850000000.0000 USD 2 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Scenario Previously Reported;
0001333986-25-000020 20230930 Other Comprehensive Income Loss Net Of Tax -62000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Other Comprehensive Income Loss Net Of Tax -6000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Other Comprehensive Income Loss Net Of Tax -10000000.0000 USD 2 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Other Comprehensive Income Loss Net Of Tax -11000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Other Comprehensive Income Loss Net Of Tax 2058000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Other Comprehensive Income Loss Net Of Tax 1182000000.0000 USD 3 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income; Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Other Comprehensive Income Loss Net Of Tax 20000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20250331 Other Comprehensive Income Loss Net Of Tax 1158000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230630 Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax -9000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax -28000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20240630 Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax -1000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax -6000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Other Cost And Expense Operating 466000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Other Cost And Expense Operating 890000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20230630 Other Cost And Expense Operating 889000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230930 Other Cost And Expense Operating 1339000000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20250331 Other Cost And Expense Operating 950000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230630 Other Depreciation Amortization And Accretion -401000000.0000 USD 2 0001333986-25-000020
0001333986-25-000020 20240331 Other Depreciation Amortization And Accretion -241000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20230930 Other Income 281000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230930 Other Income 266000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20231231 Other Income 1005000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20231231 Other Income 1014000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Other Income 425000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20221231 Other Investment Income Loss 3333000000.0000 USD 4 0001333986-25-000020
0001333986-25-000020 20230630 Other Investment Income Loss -2000000.0000 USD 1 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Other Investment Income Loss 2034000000.0000 USD 2 0001333986-25-000020
0001333986-25-000020 20230930 Other Investment Income Loss 1069000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20231231 Other Investment Income Loss -50000000.0000 USD 4 0001333986-25-000020 Restatement= Restatement Adjustment;
0001333986-25-000020 20231231 Other Investment Income Loss 4320000000.0000 USD 4 0001333986-25-000020 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Other Investment Income Loss 0.0000 USD 1 0001333986-25-000020 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Hedging Designation= Nondesignated;
0001333986-25-000020 20240630 Other Investment Income Loss 1166000000.0000 USD 1 0001333986-25-000020 Restatement= Scenario Previously Reported;
0001333986-25-000020 20250331 Other Investment Income Loss 0.0000 USD 1 0001333986-25-000020 Derivative Instrument Risk= Currency Foward; Hedging Designation= Nondesignated;
0001333986-25-000020 20250331 Other Investment Income Loss -3000000.0000 USD 1 0001333986-25-000020 Derivative Instrument Risk= Interest Rate Swap; Derivative Instruments Gain Loss By Hedging Relationship= Cash Flow Hedging; Hedging Designation= Designated As Hedging Instrument;
0001333986-25-000020 20250331 Other Investments 8971000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20231231 Other Liabilities 5976000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240930 Other Liabilities 6645000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20231231 Other Noncash Income Expense 187000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20231231 Other Noncash Income Expense 239000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Other Noncash Income Expense -15000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Payments To Acquire Available For Sale Securities Debt 3153000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230930 Policyholder Benefits And Claims Incurred Net 1000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Policyholder Contract Deposits 100228000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20241231 Policyholder Contract Deposits 110929000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20250331 Policyholder Contract Deposits 2381000000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001333986-25-000020 20240331 Preferred Stock Dividends And Other Adjustments 0.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Preferred Stock Dividends And Other Adjustments 26000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240630 Preferred Stock Dividends And Other Adjustments 0.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Preferred Stock Dividends And Other Adjustments 26000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Preferred Stock Dividends And Other Adjustments 40000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20240630 Preferred Stock Dividends And Other Adjustments 40000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Preferred Stock Dividends And Other Adjustments 14000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Premiums Earned Net -3000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Premiums Earned Net -7000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Premiums Earned Net 275000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Premiums Earned Net -1000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Proceeds From Annuities And Investment Certificates 4239000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240331 Proceeds From Sale And Maturity At Fair Value Using Fair Value Option 199000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20250331 Proceeds From Sale And Maturity At Fair Value Using Fair Value Option 131000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20250331 Proceeds From Sale Of Short Term Investments 34000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240331 Profit Loss 195000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240630 Profit Loss -22000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Profit Loss -20000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20250331 Purchase Of Noncontrolling Interests For Share Based Compensation Plan 30000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20240930 Reinsurance Payable 1421000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20231231 Reinsurance Recoverables On Paid Losses -155000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Reinsurance Recoverables On Paid Losses 8087000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240331 Repayments Of Issuance Of Debt Consolidated Variable Interest Entity 0.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20230630 Revenues 4734000000.0000 USD 2 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230930 Revenues 3633000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230930 Revenues -7000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Revenues 2230000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240331 Revenues 2230000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Revenues -3000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20250331 Right Of Use Asset Obtained In Exchange For Operating Lease Liability 15000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2336000000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001333986-25-000020 20241231 Cash And Securities Segregated Under Federal And Other Regulations 500000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 77997000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240331 Accumulated Other Comprehensive Income Loss Net Of Tax -25000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Accumulated Other Comprehensive Income Loss Net Of Tax -8675000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -8712000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001333986-25-000020 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 35000000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001333986-25-000020 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 18000000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001333986-25-000020 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 24000000.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001333986-25-000020 20240331 Assets 285469000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240930 Assets 298841000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20241231 Assets 51269000000.0000 USD 0 us-gaap/2024 Business Segments= Group Retirement; Consolidation Items= Operating Segments;
0001333986-25-000020 20241231 Assets 110358000000.0000 USD 0 us-gaap/2024 Business Segments= Individual Retirement; Consolidation Items= Operating Segments;
0001333986-25-000020 20241231 Assets 42373000000.0000 USD 0 us-gaap/2024 Business Segments= Legacy; Consolidation Items= Operating Segments;
0001333986-25-000020 20241231 Assets 168000000.0000 USD 0 us-gaap/2024 Business Segments= Wealth Management; Consolidation Items= Operating Segments;
0001333986-25-000020 20241231 Assets 2100000000.0000 USD 0 us-gaap/2024 Consolidated Entities= Consolidated Limited Partnerships;
0001333986-25-000020 20241231 Assets 39462000000.0000 USD 0 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001333986-25-000020 20250331 Assets 10845000000.0000 USD 0 us-gaap/2024 Business Segments= Asset Management; Consolidation Items= Operating Segments;
0001333986-25-000020 20250331 Assets 60000000.0000 USD 0 us-gaap/2024 Consolidated Entities= Consolidated Entity Excluding Vie; Equity Method Investment Nonconsolidated Investee= A B Sponsored Investment Funds;
0001333986-25-000020 20250331 Assets 44500000000.0000 USD 0 us-gaap/2024 Consolidated Entities= Non Consolidated Vairable Interest Entities V I E; Equity Method Investment Nonconsolidated Investee= A B Sponsored Investment Funds;
0001333986-25-000020 20221231 Benefits Losses And Expenses 9652000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230930 Benefits Losses And Expenses 2178000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230930 Benefits Losses And Expenses 6822000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20240630 Benefits Losses And Expenses -3000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20250331 Cash And Cash Equivalents At Carrying Value 8164000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 6964000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Held For Sale Including Exchange Rate Effect 0.0000 USD 0 0001333986-25-000020
0001333986-25-000020 20250331 Common Stock Par Or Stated Value Per Share 0.0100 USD 0 us-gaap/2024
0001333986-25-000020 20230930 Comprehensive Income Net Of Tax -82000000.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Comprehensive Income Net Of Tax -57000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240930 Comprehensive Income Net Of Tax 27000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Comprehensive Income Net Of Tax 372000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 407000000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 0.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 83000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240630 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest -120000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20250331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 1308000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20241231 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 2000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities;
0001333986-25-000020 20250331 Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Financial Instrument= Commercial Mortgage Backed Securities;
0001333986-25-000020 20241231 Debt Securities Available For Sale Excluding Accrued Interest 4288000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= U S Treasury And Government;
0001333986-25-000020 20241231 Debt Securities Available For Sale Excluding Accrued Interest 13699000000.0000 USD 0 us-gaap/2024 Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Asset Backed Securities;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Asset Backed Securities;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Redeemable Preferred Stock;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Residential Mortgage Backed Securities;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 648000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Asset Backed Securities;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; Financial Instrument= Redeemable Preferred Stock;
0001333986-25-000020 20250331 Debt Securities Available For Sale Excluding Accrued Interest 13885000000.0000 USD 0 us-gaap/2024 Financial Instrument= Asset Backed Securities;
0001333986-25-000020 20240331 Deferred Income Tax Assets Net 2063000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Deferred Income Tax Assets Net 2003000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240331 Deferred Policy Acquisition Cost Amortization Expense Net Investment Gains Losses 16000000.0000 USD 1 us-gaap/2024 Business Segments= Legacy; Consolidation Items= Operating Segments;
0001333986-25-000020 20231231 Deferred Policy Acquisition Costs 987000000.0000 USD 0 us-gaap/2024 Business Segments= Protection Solutions; Product Or Service= Variable Universal Life;
0001333986-25-000020 20240331 Deferred Policy Acquisition Costs 174000000.0000 USD 0 us-gaap/2024 Business Segments= Protection Solutions; Product Or Service= Universal Life;
0001333986-25-000020 20241231 Deferred Policy Acquisition Costs 1605000000.0000 USD 0 us-gaap/2024 Business Segments= Individual Retirement; Product Or Service= G Mx B Core;
0001333986-25-000020 20250331 Deferred Policy Acquisition Costs 7262000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20250331 Deferred Policy Acquisition Costs 154000000.0000 USD 0 us-gaap/2024 Business Segments= Individual Retirement; Product Or Service= E Q U I V E S T Individual;
0001333986-25-000020 20250331 Deferred Policy Acquisition Costs 236000000.0000 USD 0 us-gaap/2024 Business Segments= Individual Retirement; Product Or Service= Investment Edge;
0001333986-25-000020 20250331 Deferred Policy Acquisition Costs 504000000.0000 USD 0 us-gaap/2024 Business Segments= Legacy Segment; Product Or Service= G Mx B Legacy;
0001333986-25-000020 20240331 Derivative Gain Loss On Derivative Net 241000000.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Equity Futures; Hedging Designation= Nondesignated;
0001333986-25-000020 20240331 Derivative Gain Loss On Derivative Net 0.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Interest Rate Swap; Derivative Instruments Gain Loss By Hedging Relationship= Cash Flow Hedging; Hedging Designation= Designated As Hedging Instrument;
0001333986-25-000020 20250331 Derivative Gain Loss On Derivative Net 799000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20250331 Derivative Gain Loss On Derivative Net 0.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Collateralized Securities; Hedging Designation= Nondesignated;
0001333986-25-000020 20250331 Derivative Gain Loss On Derivative Net 2978000000.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Embedded Derivative Financial Instruments; Hedging Designation= Nondesignated;
0001333986-25-000020 20250331 Derivative Gain Loss On Derivative Net 2978000000.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Embedded Derivative Non G Mx B Insurance Products; Hedging Designation= Nondesignated;
0001333986-25-000020 20250331 Derivative Gain Loss On Derivative Net 15000000.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Interest Rate Swap; Hedging Designation= Nondesignated;
0001333986-25-000020 20250331 Dividends Common Stock 74000000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001333986-25-000020 20240331 Dividends Preferred Stock 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001333986-25-000020 20250331 Dividends Preferred Stock 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001333986-25-000020 20250331 Dividends Preferred Stock 14000000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001333986-25-000020 20240331 Earnings Per Share Basic -0.0600 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Earnings Per Share Basic 1.2400 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Earnings Per Share Basic 1.0900 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230930 Earnings Per Share Diluted 3.0200 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Earnings Per Share Diluted -0.4700 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Earnings Per Share Diluted 1.0800 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Equity Income Loss From Limited Partnerships -50000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20250331 Equity Income Loss From Limited Partnerships -28000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20241231 Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001333986-25-000020 20250331 Gains Loss On Investments And Disposition Of Business -14000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20250331 Goodwill And Other Intangible Assets Net 5356000000.0000 USD 0 0001333986-25-000020
0001333986-25-000020 20230930 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -20000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 1475000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230930 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 1555000000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 247000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 0.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -28000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -35000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230630 Income Tax Expense Benefit -1000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20230930 Income Tax Expense Benefit -683000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20240331 Income Tax Expense Benefit 24000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230630 Increase Decrease In Accrued Income Taxes Payable -2000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Increase Decrease In Accrued Income Taxes Payable -6000000.0000 USD 1 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Increase Decrease In Broker Dealer Related Receivables Payables Net 24000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20240331 Increase Decrease In Collateralized Pledged Assets -171000000.0000 USD 1 0001333986-25-000020
0001333986-25-000020 20221231 Increase Decrease In Employee Related Liabilities 275000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20250331 Increase Decrease In Employee Related Liabilities 26000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20250331 Increase Decrease In Future Policy Benefit Reserves 28000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20231231 Increase Decrease In Reinsurance Recoverable -2000000.0000 USD 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240331 Insurance Commissions 40000000.0000 USD 1 us-gaap/2024 Business Segments= Protection Solutions; Consolidation Items= Operating Segments;
0001333986-25-000020 20230630 Interest Credited To Policyholders Account Balances 498000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230930 Interest Credited To Policyholders Account Balances 552000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20231231 Interest Credited To Policyholders Account Balances 2083000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Interest Credited To Policyholders Account Balances 566000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Interest Credited To Policyholders Account Balances 605000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Interest Credited To Policyholders Account Balances 1178000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20240930 Interest Credited To Policyholders Account Balances 0.0000 USD 3 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240930 Interest Credited To Policyholders Account Balances 1879000000.0000 USD 3 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Interest Credited To Policyholders Account Balances 2493000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20250331 Interest Credited To Policyholders Account Balances 2000000.0000 USD 1 us-gaap/2024 Business Segments= Individual Retirement; Product Or Service= Core1;
0001333986-25-000020 20250331 Interest Credited To Policyholders Account Balances 32000000.0000 USD 1 us-gaap/2024 Business Segments= Protection Solutions; Product Or Service= Variable Universal Life;
0001333986-25-000020 20250331 Investments 118908000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20241231 Investments Fixed Maturities Fair Value Option Variable Interest Entity 275000000.0000 USD 0 0001333986-25-000020 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001333986-25-000020 20241231 Investments Fixed Maturities Fair Value Option Variable Interest Entity 2053000000.0000 USD 0 0001333986-25-000020 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001333986-25-000020 20250331 Investments Fixed Maturities Fair Value Option Variable Interest Entity 2105000000.0000 USD 0 0001333986-25-000020
0001333986-25-000020 20250331 Investments Fixed Maturities Fair Value Option Variable Interest Entity 0.0000 USD 0 0001333986-25-000020 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001333986-25-000020 20221231 Labor And Related Expense 2201000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20230630 Labor And Related Expense 565000000.0000 USD 1 us-gaap/2024
0001333986-25-000020 20230630 Labor And Related Expense -5000000.0000 USD 2 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Labor And Related Expense 2441000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20231231 Liabilities 271656000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240331 Liabilities -68000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Liabilities -84000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20241231 Liabilities 1000000.0000 USD 0 us-gaap/2024 Consolidated Entities= Consolidated Entity Excluding Vie; Equity Method Investment Nonconsolidated Investee= A B Sponsored Investment Funds;
0001333986-25-000020 20241231 Liabilities -119000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Liabilities And Stockholders Equity -130000000.0000 USD 0 us-gaap/2024 Restatement= Restatement Adjustment;
0001333986-25-000020 20240630 Liabilities And Stockholders Equity 287769000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20241231 Liabilities And Stockholders Equity 295727000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20231231 Liability For Future Policy Benefit Remeasurement Gain Loss -86000000.0000 USD 4 us-gaap/2024
0001333986-25-000020 20240930 Liability For Future Policy Benefit Remeasurement Gain Loss -16000000.0000 USD 1 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240930 Liability For Future Policy Benefit Remeasurement Gain Loss 3000000.0000 USD 3 us-gaap/2024
0001333986-25-000020 20240331 Liability For Future Policy Benefits 17324000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20250331 Liability For Future Policy Benefits 5142000000.0000 USD 0 us-gaap/2024 Product Or Service= Whole Life Closed Block And Open Block Products;
0001333986-25-000020 20241231 Loans Insurance Policy 4330000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20241231 Loans Insurance Policy 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001333986-25-000020 20250331 Loans Insurance Policy 4553000000.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure;
0001333986-25-000020 20231231 Market Risk Benefit Asset Amount 594000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20241231 Market Risk Benefit Asset Amount 863000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20221231 Market Risk Benefit Change In Fair Value Gain Loss 1280000000.0000 USD 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001333986-25-000020 20240630 Market Risk Benefit Change In Fair Value Gain Loss 1220000000.0000 USD 2 us-gaap/2024
0001333986-25-000020 20250331 Market Risk Benefit Liability Amount 10864000000.0000 USD 0 us-gaap/2024
0001333986-25-000020 20240630 Minority Interest 1741000000.0000 USD 0 us-gaap/2024 Restatement= Scenario Previously Reported;

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.
Proceeds From Issuance Of Long Term Debt us-gaap/2024 0 0 monetary D D Proceeds from Issuance of Long-Term Debt The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Market Risk Benefit Asset Amount us-gaap/2024 0 0 monetary I D Market Risk Benefit, Asset, Amount Amount of asset position for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.
Investment In Capitalized Software Leasehold Improvements And E D P Equipment 0001333986-25-000020 1 0 monetary D C Investment In Capitalized Software, Leasehold Improvements And EDP Equipment Purchase/Sales of capitalized software, leasehold improvements and EDP Equipment
Gain Loss On Sale Of Business us-gaap/2024 0 0 monetary D C Gain (Loss) on Disposition of Business Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.
Minority Interest Decrease From Redemptions us-gaap/2024 0 0 monetary D D Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).
Right Of Use Asset Obtained In Exchange For Operating Lease Liability us-gaap/2024 0 0 monetary D D Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Amount of increase in right-of-use asset obtained in exchange for operating lease liability.
Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary I C Equity, Including Portion Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.
Gains Loss On Investments And Disposition Of Business 0001333986-25-000020 1 0 monetary D C Gains (Loss) On Investments And Disposition Of Business Gains (Loss) On Investments And Disposition Of Business
Notes Issued By Consolidated Variable Interest Entity Fair Value Option 0001333986-25-000020 1 0 monetary I C Notes Issued By Consolidated Variable Interest Entity, Fair Value Option Notes Issued By Consolidated Variable Interest Entity, Fair Value Option
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D D Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.
Deferred Income Tax Assets Net us-gaap/2024 0 0 monetary I D Deferred Income Tax Assets, Net Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Deferred Policy Acquisition Costs us-gaap/2024 0 0 monetary I D Deferred Policy Acquisition Cost Amount of deferred policy acquisition cost capitalized on contract remaining in force.
Gain Loss On Investments us-gaap/2024 0 0 monetary D C Gain (Loss) on Investments Amount of realized and unrealized gain (loss) on investment.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Liability For Future Policy Benefits us-gaap/2024 0 0 monetary I C Liability for Future Policy Benefit, before Reinsurance Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.
Loans Insurance Policy us-gaap/2024 0 0 monetary I D Loans, Gross, Insurance Policy Amount before allowance of loans made to policy and contract holders using their life insurance contracts' cash value or separate accounts as collateral. Includes deferred interest and fees, undisbursed portion of loan balance, unamortized costs and premiums over and discounts from face amounts. Excludes loans and leases covered under loss sharing agreements.
Net Income Loss Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D D Net Income (Loss) Attributable to Noncontrolling Interest Amount of Net Income (Loss) attributable to noncontrolling interest.
Other Income us-gaap/2024 0 0 monetary D C Other Income Amount of revenue and income classified as other.
Preferred Stock Liquidation Preference Value us-gaap/2024 0 0 monetary I C Preferred Stock, Liquidation Preference, Value Value of the difference between preference in liquidation and the par or stated values of the preferred shares.
Proceeds From Sale And Collection Of Mortgage Notes Receivable us-gaap/2024 0 0 monetary D D Proceeds from Sale and Collection of Mortgage Notes Receivable The cash inflow from proceeds from sale of receivables arising from the mortgage note on real estate; includes collections on mortgage notes receivable that are not classified as operating cash flows.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Stock Redeemed Or Called During Period Value us-gaap/2024 0 0 monetary D D Stock Redeemed or Called During Period, Value Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.
Repayments Of Collateralized Loan Obligations 0001333986-25-000020 1 0 monetary D C Repayments Of Collateralized Loan Obligations Repayments Of Collateralized Loan Obligations
Equity Income Loss From Limited Partnerships 0001333986-25-000020 1 0 monetary D D Equity Income (Loss) From Limited Partnerships Equity Income (Loss) From Limited Partnerships
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Dividends Per Share Declared us-gaap/2024 0 0 perShare D Common Stock, Dividends, Per Share, Declared Aggregate dividends declared during the period for each share of common stock outstanding.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Reinsurance Recoverables On Paid Losses us-gaap/2024 0 0 monetary I D Reinsurance Recoverable for Paid Claims and Claims Adjustments Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to and paid by the ceding insurer.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Stockholders Equity Other us-gaap/2024 0 0 monetary D D Stockholders' Equity, Other This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Goodwill And Other Intangible Assets Net 0001333986-25-000020 1 0 monetary I D Goodwill And Other Intangible Assets, Net Goodwill plus Other Intangible Assets.
Investments Fixed Maturities Fair Value Option Variable Interest Entity 0001333986-25-000020 1 0 monetary I D Investments, Fixed Maturities, Fair Value Option, Variable Interest Entity Investments, Fixed Maturities, Fair Value Option, Variable Interest Entity
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax1 0001333986-25-000020 1 0 monetary D C Other Comprehensive Income (Loss), Available-For-Sale Securities Adjustment, Net Of Tax1 Net of tax amount of the appreciation (loss) in the value of unsold available-for-sale securities. Includes amounts related to other than temporary impairment (OTTI) losses.
Payments Of Market Risk Benefits 0001333986-25-000020 1 0 monetary D C Payments Of Market Risk Benefits Payments Of Market Risk Benefits
Purchased Market Risk Benefits 0001333986-25-000020 1 0 monetary I D Purchased Market Risk Benefits Purchased Market Risk Benefits
Benefits Losses And Expenses us-gaap/2024 0 0 monetary D D Benefits, Losses and Expenses The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary D D Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Insurance Commissions us-gaap/2024 0 0 monetary D D Insurance Commissions The expense incurred by an insurance company to persons or entities for generating or placing insurance or investment contracts with the company, usually determined as a percentage of policy or contract premiums. Excludes advances or draws to be applied against commissions earned.
Net Income Loss Available To Common Stockholders Diluted us-gaap/2024 0 0 monetary D C Net Income (Loss) Available to Common Stockholders, Diluted Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.
Payments For Proceeds From Other Investing Activities us-gaap/2024 0 0 monetary D C Payments for (Proceeds from) Other Investing Activities Amount of cash (inflow) outflow from investing activities classified as other.
Policyholder Benefits And Claims Incurred Net us-gaap/2024 0 0 monetary D D Policyholder Benefits and Claims Incurred, Net Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.
Separate Account Assets us-gaap/2024 0 0 monetary I D Separate Account Asset Amount of asset at fair value held for benefit of separate account policyholder.
Payables To Customers srt/2024 0 0 monetary I C Broker-Dealer, Payable to Customer Amount payable to customer by broker-dealer.
Increase Decrease In Cash And Securities Segregated Under Federal And Other Regulations 0001333986-25-000020 1 0 monetary D C Increase (Decrease) In Cash And Securities Segregated Under Federal And Other Regulations The change during the period, either increase or decrease, in the amount of cash subject to withdrawal restrictions, restricted deposits, and cash and securities segregated in compliance with regulations (such as cash deposited in a special reserve account for the exclusive benefit of customers).
Other Investment Income Loss 0001333986-25-000020 1 0 monetary D C Other Investment Income (Loss) Other investment income
Proceeds From Sale And Maturity At Fair Value Using Fair Value Option 0001333986-25-000020 1 0 monetary D D Proceeds From Sale And Maturity At Fair Value Using Fair Value Option Proceeds From Sale And Maturity At Fair Value Using Fair Value Option
Dividends Common Stock us-gaap/2024 0 0 monetary D D Dividends, Common Stock Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).
Deferred Policy Acquisition Cost Amortization Expense Net Investment Gains Losses us-gaap/2024 0 0 monetary D D Deferred Policy Acquisition Cost, Amortization Expense, Net Investment Gains (Losses) Amount of amortization expense (reversal of amortization expense) of deferred policy acquisition costs from realized net investment gain (loss).
Increase Decrease In Accrued Income Taxes Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Income Taxes Payable The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.
Market Risk Benefit Change In Fair Value Gain Loss us-gaap/2024 0 0 monetary D C Market Risk Benefit, Change in Fair Value, Gain (Loss) Amount of gain (loss) from (increase) decrease in fair value of contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk. Excludes change attributable to instrument-specific credit risk.
Market Risk Benefit Liability Amount us-gaap/2024 0 0 monetary I C Market Risk Benefit, Liability, Amount Amount of liability position for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk.
Other Cost And Expense Operating us-gaap/2024 0 0 monetary D D Other Cost and Expense, Operating The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.
Payments To Acquire Available For Sale Securities Debt us-gaap/2024 0 0 monetary D C Payments to Acquire Debt Securities, Available-for-Sale Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Annuities And Investment Certificates Transfer To From Separate Accounts 0001333986-25-000020 1 0 monetary D D Annuities And Investment Certificates, Transfer (To) From Separate Accounts Annuities And Investment Certificates, Transfer (To) From Separate Accounts
Income Loss Due To Novation In Pre Tax Net Income 0001333986-25-000020 1 0 monetary D C Income (Loss) due to Novation in Pre-Tax Net Income Income (loss) due to Novation in pre-tax net income
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss us-gaap/2024 0 0 monetary I D Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease.
Increase Decrease In Employee Related Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Employee Related Liabilities The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.
Increase Decrease In Securities Lending Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Securities Lending Payable The increase (decrease) during the period in the carrying amount of the liability pertaining to obligations to return collateral that the entity received when it loaned securities to the counterparty to the transaction.
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders us-gaap/2024 0 0 monetary D D Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.
Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Net of Tax Amount after tax and reclassification adjustments of other comprehensive income (loss).
Other Noncash Income Expense us-gaap/2024 0 0 monetary D C Other Noncash Income (Expense) Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.
Premiums Earned Net us-gaap/2024 0 0 monetary D C Premiums Earned, Net Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.
Proceeds From Sale Of Short Term Investments us-gaap/2024 0 0 monetary D D Proceeds from Sale of Short-Term Investments The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.
Profit Loss us-gaap/2024 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
Repayments Of Annuities And Investment Certificates us-gaap/2024 0 0 monetary D C Repayments of Annuities and Investment Certificates The cash outflow for an insurance contract under which the policy holder make a lump sum payment or a series of payments in exchange for periodic payments to the policyholder beginning immediately or at some future date.
Separate Accounts Liability us-gaap/2024 0 0 monetary I C Separate Account, Liability Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.
Stock Repurchased And Retired During Period Value us-gaap/2024 0 0 monetary D D Stock Repurchased and Retired During Period, Value Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).
Short Term Borrowings us-gaap/2024 0 0 monetary I C Short-Term Debt Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
Increase Decrease In Future Policy Benefit Reserves us-gaap/2024 0 0 monetary D D Increase (Decrease) in Future Policy Benefit Reserves The change in the future policy benefit reserve balance on the balance sheet.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Stock Issued During Period Value Treasury Stock Reissued us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Treasury Stock Reissued Value of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Other Depreciation Amortization And Accretion 0001333986-25-000020 1 0 monetary D C Other Depreciation, Amortization And Accretion Other Depreciation, Amortization And Accretion
Repayments Of Issuance Of Debt Consolidated Variable Interest Entity 0001333986-25-000020 1 0 monetary D C Repayments Of Issuance Of Debt, Consolidated Variable Interest Entity Repayments Of Issuance Of Debt, Consolidated Variable Interest Entity
Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss us-gaap/2024 0 0 monetary I D Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss Amortized cost excluding accrued interest, before allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Increase Decrease In Broker Dealer Related Receivables Payables Net us-gaap/2024 0 0 monetary D C Increase (Decrease) in Broker-Dealer Related Receivables (Payables), Net The increase (decrease) during the reporting period in receivables or payables that result from buying and selling securities for the firm's own account or from acting as an agent or intermediary in the sale of securities.
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax us-gaap/2024 0 0 monetary D D Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.
Increase Decrease In Collateralized Pledged Assets 0001333986-25-000020 1 0 monetary D D Increase (Decrease) In Collateralized Pledged Assets Increase in collateralized pledged assets
Redeemable Noncontrolling Interest Equity Carrying Amount us-gaap/2024 0 0 monetary I C Redeemable Noncontrolling Interest, Equity, Carrying Amount As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.
Revenues us-gaap/2024 0 0 monetary D C Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Purchase Of Noncontrolling Interests For Share Based Compensation Plan 0001333986-25-000020 1 0 monetary D C Purchase Of Noncontrolling Interests For Share-Based Compensation Plan Purchase Of Noncontrolling Interests For Share-Based Compensation Plan
Cash And Securities Segregated Under Federal And Other Regulations us-gaap/2024 0 0 monetary I D Cash and Securities Segregated under Federal and Other Regulations Amount of cash subject to withdrawal restrictions, restricted deposits held as compensating balances, and cash and securities segregated in compliance with regulations (such as cash deposited in a special reserve account for the exclusive benefit of customers).
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Debt Securities Available For Sale Excluding Accrued Interest us-gaap/2024 0 0 monetary I D Debt Securities, Available-for-Sale, Excluding Accrued Interest Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Dividends Preferred Stock us-gaap/2024 0 0 monetary D D Dividends, Preferred Stock Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).
Labor And Related Expense us-gaap/2024 0 0 monetary D D Labor and Related Expense Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.
Liability For Future Policy Benefit Remeasurement Gain Loss us-gaap/2024 0 0 monetary D C Liability for Future Policy Benefit, Remeasurement Gain (Loss) Amount of remeasurement gain (loss) on liability for future policy benefit from application of revised benefit ratio as of contract issue. Includes, but is not limited to, remeasurement gain (loss) for annuitization insurance benefit, death and other insurance benefits, and traditional and limited-payment contracts.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Net Income Loss Available To Common Stockholders Basic us-gaap/2024 0 0 monetary D C Net Income (Loss) Available to Common Stockholders, Basic Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
Other Liabilities us-gaap/2024 0 0 monetary I C Other Liabilities Amount of liabilities classified as other.
Preferred Stock Dividends And Other Adjustments us-gaap/2024 0 0 monetary D D Preferred Stock Dividends and Other Adjustments The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.
Gain Loss On Other Investments Net 0001333986-25-000020 1 0 monetary D C Gain (Loss) On Other Investments, Net Gain (Loss) On Other Investments, Net
Increase Decrease In Bank Overdrafts 0001333986-25-000020 1 0 monetary D D Increase (Decrease) In Bank Overdrafts Increase (Decrease) In Bank Overdrafts
Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk 0001333986-25-000020 1 0 monetary D D Other Comprehensive Income (Loss), Market Risk Benefit, After Adjustment From Instrument Of Special Credit Risk Other Comprehensive Income (Loss), Market Risk Benefit, After Adjustment From Instrument Of Special Credit Risk
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest us-gaap/2024 0 0 monetary I C Debt Securities, Available-for-Sale, Allowance for Credit Loss, Excluding Accrued Interest Amount excluding accrued interest, of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Financing Receivable Allowance For Credit Loss Excluding Accrued Interest us-gaap/2024 0 0 monetary I C Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest Amount excluding accrued interest, of allowance for credit loss on financing receivable. Excludes net investment in lease.
Increase Decrease In Reinsurance Recoverable us-gaap/2024 0 0 monetary D C Increase (Decrease) in Reinsurance Recoverable The increase (decrease) during the reporting period in the amount of benefits the ceding insurer expects to recover on insurance policies ceded to other insurance entities as of the balance sheet date for all guaranteed benefit types.
Interest Credited To Policyholders Account Balances us-gaap/2024 0 0 monetary D D Policyholder Account Balance, Interest Expense Amount of interest expense for allocation to policyholder account balance.
Other Investments us-gaap/2024 0 0 monetary I D Other Investments Amount of investments classified as other.
Payments For Proceeds From Derivative Instrument Investing Activities us-gaap/2024 0 0 monetary D C Payments for (Proceeds from) Derivative Instrument, Investing Activities The net cash outflow or inflow from derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.
Proceeds From Annuities And Investment Certificates us-gaap/2024 0 0 monetary D D Proceeds from Annuities and Investment Certificates The cash inflow from an insurance contract under which the policy holder make a lump sum payment or a series of payments in exchange for periodic payments to the policyholder beginning immediately or at some future date.
Reinsurance Payable us-gaap/2024 0 0 monetary I C Reinsurance Payable The carrying amount as of the balance sheet date of the known and estimated amounts owed to insurers under reinsurance treaties or other arrangements.
Trading Securities Debt us-gaap/2024 0 0 monetary I D Debt Securities, Trading Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading).
Derivative Gain Loss On Derivative Net us-gaap/2024 0 0 monetary D C Derivative, Gain (Loss) on Derivative, Net Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Held For Sale Including Exchange Rate Effect 0001333986-25-000020 1 0 monetary I D Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents, Held-For-Sale, Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents, Held-For-Sale, Including Exchange Rate Effect
Credit And Intent To Sell Losses On Available For Sale Debt Securities And Loans 0001333986-25-000020 1 0 monetary D D Credit And Intent To Sell, Losses On Available-For-Sale Debt Securities And Loans Credit And Intent To Sell, Losses On Available-For-Sale Debt Securities And Loans
Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest 0001333986-25-000020 1 0 monetary D C Net Income (Loss), Portion Attributable To Non-Redeemable Noncontrolling Interest Net Income (Loss), Portion Attributable To Non-Redeemable Noncontrolling Interest
Investments us-gaap/2024 0 0 monetary I D Investments Sum of the carrying amounts as of the balance sheet date of all investments.
Long Term Debt Noncurrent us-gaap/2024 0 0 monetary I C Long-Term Debt, Excluding Current Maturities Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.
Minority Interest us-gaap/2024 0 0 monetary I C Equity, Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.
Other Assets us-gaap/2024 0 0 monetary I D Other Assets Amount of assets classified as other.
Payments Of Dividends Preferred Stock And Preference Stock us-gaap/2024 0 0 monetary D C Payments of Ordinary Dividends, Preferred Stock and Preference Stock Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.
Policyholder Contract Deposits us-gaap/2024 0 0 monetary I C Policyholder Contract Deposit Amount of liability due to policyholder for deposit held under long-duration contract issued by insurance entity.
Treasury Stock Value Acquired Cost Method us-gaap/2024 0 0 monetary D D Treasury Stock, Value, Acquired, Cost Method Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Investment Management And Service Fees 0001333986-25-000020 1 0 monetary D C Investment Management And Service Fees Investment Management And Service Fees

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001333986-25-000020 2 3 BS 0 H Debt Securities Available For Sale Excluding Accrued Interest us-gaap/2024 Fixed maturities available-for-sale, at fair value (amortized cost of $85,230 and $84,717) (allowance for credit losses of $7 and $2) 0
0001333986-25-000020 2 4 BS 0 H Investments Fixed Maturities Fair Value Option Variable Interest Entity 0001333986-25-000020 Fixed maturities, at fair value using the fair value option 0
0001333986-25-000020 2 5 BS 0 H Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss us-gaap/2024 Mortgage loans on real estate (net of allowance for credit losses of $278 and $279) 0
0001333986-25-000020 2 6 BS 0 H Loans Insurance Policy us-gaap/2024 Policy loans 0
0001333986-25-000020 2 7 BS 0 H Other Equity Investments 0001333986-25-000020 Other equity investments 0
0001333986-25-000020 2 8 BS 0 H Trading Securities Debt us-gaap/2024 Trading securities, at fair value 0
0001333986-25-000020 2 9 BS 0 H Other Investments us-gaap/2024 Other invested assets 0
0001333986-25-000020 2 10 BS 0 H Investments us-gaap/2024 Total investments 0
0001333986-25-000020 2 11 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001333986-25-000020 2 12 BS 0 H Cash And Securities Segregated Under Federal And Other Regulations us-gaap/2024 Cash and securities segregated, at fair value 0
0001333986-25-000020 2 13 BS 0 H Receivables From Brokers Dealers And Clearing Organizations us-gaap/2024 Broker-dealer related receivables 0
0001333986-25-000020 2 14 BS 0 H Deferred Policy Acquisition Costs us-gaap/2024 Deferred policy acquisition costs 0
0001333986-25-000020 2 15 BS 0 H Goodwill And Other Intangible Assets Net 0001333986-25-000020 Goodwill and other intangible assets, net 0
0001333986-25-000020 2 16 BS 0 H Reinsurance Recoverables On Paid Losses us-gaap/2024 Amounts due from reinsurers (allowance for credit losses of $7 and $8) 0
0001333986-25-000020 2 17 BS 0 H Deferred Income Tax Assets Net us-gaap/2024 Current and deferred income taxes 0
0001333986-25-000020 2 18 BS 0 H Purchased Market Risk Benefits 0001333986-25-000020 Purchased market risk benefits 0
0001333986-25-000020 2 19 BS 0 H Other Assets us-gaap/2024 Other assets 0
0001333986-25-000020 2 20 BS 0 H Market Risk Benefit Asset Amount us-gaap/2024 Assets for market risk benefits 0
0001333986-25-000020 2 21 BS 0 H Separate Account Assets us-gaap/2024 Separate Accounts assets 0
0001333986-25-000020 2 22 BS 0 H Assets us-gaap/2024 Total Assets 0
0001333986-25-000020 2 24 BS 0 H Policyholder Contract Deposits us-gaap/2024 Policyholders account balances 0
0001333986-25-000020 2 25 BS 0 H Market Risk Benefit Liability Amount us-gaap/2024 Liability for market risk benefits 0
0001333986-25-000020 2 26 BS 0 H Liability For Future Policy Benefits us-gaap/2024 Future policy benefits and other policyholders liabilities 0
0001333986-25-000020 2 27 BS 0 H Payables To Broker Dealers And Clearing Organizations srt/2024 Broker-dealer related payables 0
0001333986-25-000020 2 28 BS 0 H Payables To Customers srt/2024 Customer related payables 0
0001333986-25-000020 2 29 BS 0 H Reinsurance Payable us-gaap/2024 Amounts due to reinsurers 0
0001333986-25-000020 2 30 BS 0 H Short Term Borrowings us-gaap/2024 Short-term debt 0
0001333986-25-000020 2 31 BS 0 H Long Term Debt Noncurrent us-gaap/2024 Long-term debt 0
0001333986-25-000020 2 32 BS 0 H Notes Issued By Consolidated Variable Interest Entity Fair Value Option 0001333986-25-000020 Notes issued by consolidated variable interest entities, at fair value using the fair value option 0
0001333986-25-000020 2 33 BS 0 H Other Liabilities us-gaap/2024 Other liabilities 0
0001333986-25-000020 2 34 BS 0 H Separate Accounts Liability us-gaap/2024 Separate Accounts liabilities 0
0001333986-25-000020 2 35 BS 0 H Liabilities us-gaap/2024 Total Liabilities 0
0001333986-25-000020 2 36 BS 0 H Redeemable Noncontrolling Interest Equity Carrying Amount us-gaap/2024 Redeemable noncontrolling interest 0
0001333986-25-000020 2 37 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and contingent liabilities 0
0001333986-25-000020 2 40 BS 0 H Preferred Stock And Additional Paid In Capital Value Issued 0001333986-25-000020 Preferred stock and additional paid-in capital, $1 par value and $25,000 liquidation preference 0
0001333986-25-000020 2 41 BS 0 H Common Stock Value us-gaap/2024 Common stock, $0.01 par value, 2,000,000,000 shares authorized; 475,091,056 and 477,801,636 shares issued, respectively; 306,340,799 and 309,900,248 shares outstanding, respectively 0
0001333986-25-000020 2 42 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0001333986-25-000020 2 43 BS 0 H Treasury Stock Common Value us-gaap/2024 Treasury stock, at cost,$168,750,257 and 167,901,388 shares, respectively 1
0001333986-25-000020 2 44 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Retained earnings 0
0001333986-25-000020 2 45 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive income (loss) 0
0001333986-25-000020 2 46 BS 0 H Stockholders Equity us-gaap/2024 Total equity attributable to Holdings 0
0001333986-25-000020 2 47 BS 0 H Minority Interest us-gaap/2024 Noncontrolling interest 0
0001333986-25-000020 2 48 BS 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Total Equity 0
0001333986-25-000020 2 49 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total Liabilities, Redeemable Noncontrolling Interest and Equity 0
0001333986-25-000020 3 1 BS 1 H Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss us-gaap/2024 Amortized cost of fixed maturities available-for-sale 0
0001333986-25-000020 3 2 BS 1 H Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest us-gaap/2024 Allowance for credit losses of fixed maturities available-for-sale 0
0001333986-25-000020 3 3 BS 1 H Financing Receivable Allowance For Credit Loss Excluding Accrued Interest us-gaap/2024 Allowance for credit losses of mortgage loans on real estate 0
0001333986-25-000020 3 4 BS 1 H Reinsurance Recoverables Allowance us-gaap/2024 Allowance for credit losses of amounts due from reinsurers 0
0001333986-25-000020 3 5 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred stock par value (in dollars per share) 0
0001333986-25-000020 3 6 BS 1 H Preferred Stock Liquidation Preference Value us-gaap/2024 Preferred stock, liquidation preference 0
0001333986-25-000020 3 7 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock par value (in dollars per share) 0
0001333986-25-000020 3 8 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock authorized (in shares) 0
0001333986-25-000020 3 9 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock issued (in shares) 0
0001333986-25-000020 3 10 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock outstanding (in shares) 0
0001333986-25-000020 3 11 BS 1 H Treasury Stock Common Shares us-gaap/2024 Treasury stock (in shares) 0
0001333986-25-000020 4 2 IS 0 H Insurance Commissions And Fees us-gaap/2024 Policy charges and fee income 0
0001333986-25-000020 4 3 IS 0 H Premiums Earned Net us-gaap/2024 Premiums 0
0001333986-25-000020 4 4 IS 0 H Derivative Gain Loss On Derivative Net us-gaap/2024 Net derivative gains (losses) 0
0001333986-25-000020 4 5 IS 0 H Other Investment Income Loss 0001333986-25-000020 Net investment income (loss) 0
0001333986-25-000020 4 7 IS 0 H Credit And Intent To Sell Losses On Available For Sale Debt Securities And Loans 0001333986-25-000020 Credit and intent to sell losses on available for sale debt securities and loans 1
0001333986-25-000020 4 8 IS 0 H Gain Loss On Other Investments Net 0001333986-25-000020 Other investment gains (losses), net 0
0001333986-25-000020 4 9 IS 0 H Gains Loss On Investments And Disposition Of Business 0001333986-25-000020 Total investment gains (losses), net 0
0001333986-25-000020 4 10 IS 0 H Investment Management And Service Fees 0001333986-25-000020 Investment management and service fees 0
0001333986-25-000020 4 11 IS 0 H Other Income us-gaap/2024 Other income 0
0001333986-25-000020 4 12 IS 0 H Revenues us-gaap/2024 Total revenues 0
0001333986-25-000020 4 14 IS 0 H Policyholder Benefits And Claims Incurred Net us-gaap/2024 Policyholders benefits 0
0001333986-25-000020 4 15 IS 0 H Liability For Future Policy Benefit Remeasurement Gain Loss us-gaap/2024 Remeasurement of liability for future policy benefits 1
0001333986-25-000020 4 16 IS 0 H Market Risk Benefit Change In Fair Value Gain Loss us-gaap/2024 Change in market risk benefits and purchased market risk benefits 1
0001333986-25-000020 4 17 IS 0 H Interest Credited To Policyholders Account Balances us-gaap/2024 Interest credited to policyholders account balances 0
0001333986-25-000020 4 18 IS 0 H Labor And Related Expense us-gaap/2024 Compensation and benefits 0
0001333986-25-000020 4 19 IS 0 H Insurance Commissions us-gaap/2024 Commissions and distribution-related payments 0
0001333986-25-000020 4 20 IS 0 H Interest Expense Operating us-gaap/2024 Interest expense 0
0001333986-25-000020 4 21 IS 0 H Deferred Policy Acquisition Cost Amortization Expense Net Investment Gains Losses us-gaap/2024 Amortization of deferred policy acquisition costs 0
0001333986-25-000020 4 22 IS 0 H Other Cost And Expense Operating us-gaap/2024 Other operating costs and expenses 0
0001333986-25-000020 4 23 IS 0 H Benefits Losses And Expenses us-gaap/2024 Total benefits and other deductions 0
0001333986-25-000020 4 24 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 Income (loss) from continuing operations, before income taxes 0
0001333986-25-000020 4 25 IS 0 H Income Tax Expense Benefit us-gaap/2024 Income tax (expense) benefit 1
0001333986-25-000020 4 26 IS 0 H Profit Loss us-gaap/2024 Net income (loss) 0
0001333986-25-000020 4 27 IS 0 H Net Income Loss Attributable To Noncontrolling Interest us-gaap/2024 Less: Net income (loss) attributable to the noncontrolling interest 0
0001333986-25-000020 4 28 IS 0 H Net Income Loss us-gaap/2024 Net income (loss) attributable to Holdings 0
0001333986-25-000020 4 29 IS 0 H Preferred Stock Dividends And Other Adjustments us-gaap/2024 Less: Preferred stock dividends 0
0001333986-25-000020 4 30 IS 0 H Net Income Loss Available To Common Stockholders Basic us-gaap/2024 Net income (loss) available to Holdings common shareholders, basic 0
0001333986-25-000020 4 31 IS 0 H Net Income Loss Available To Common Stockholders Diluted us-gaap/2024 Net income (loss) available to Holdings common shareholders, diluted 0
0001333986-25-000020 4 34 IS 0 H Earnings Per Share Basic us-gaap/2024 Basic (in dollars per share) 0
0001333986-25-000020 4 35 IS 0 H Earnings Per Share Diluted us-gaap/2024 Diluted (in dollars per share) 0
0001333986-25-000020 4 37 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Basic (in shares) 0
0001333986-25-000020 4 38 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Diluted (in shares) 0
0001333986-25-000020 5 1 CI 0 H Profit Loss us-gaap/2024 Net income (loss) 0
0001333986-25-000020 5 3 CI 0 H Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax1 0001333986-25-000020 Change in unrealized gains (losses), net of reclassification adjustment 0
0001333986-25-000020 5 4 CI 0 H Other Comprehensive Income Loss Market Risk Benefit After Adjustment From Instrument Of Special Credit Risk 0001333986-25-000020 Change in market risk benefits - instrument-specific credit risk 1
0001333986-25-000020 5 5 CI 0 H Other Comprehensive Income Loss Current Discount Rate Adjustment For Future Policy Benefits 0001333986-25-000020 Change in liability for future policy benefits - current discount rate 1
0001333986-25-000020 5 6 CI 0 H Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax us-gaap/2024 Change in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment 1
0001333986-25-000020 5 7 CI 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation adjustment 0
0001333986-25-000020 5 8 CI 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Total other comprehensive income (loss), net of income taxes 0
0001333986-25-000020 5 9 CI 0 H Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Comprehensive income (loss) 0
0001333986-25-000020 5 10 CI 0 H Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest us-gaap/2024 Less: Comprehensive income (loss) attributable to the noncontrolling interest 0
0001333986-25-000020 5 11 CI 0 H Comprehensive Income Net Of Tax us-gaap/2024 Comprehensive income (loss) attributable to Holdings 0
0001333986-25-000020 6 14 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Balance, beginning of period 0
0001333986-25-000020 6 15 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Stock compensation 0
0001333986-25-000020 6 16 EQ 0 H Treasury Stock Value Acquired Cost Method us-gaap/2024 Purchase of treasury stock 1
0001333986-25-000020 6 17 EQ 0 H Stock Issued During Period Value Treasury Stock Reissued us-gaap/2024 Reissuance of treasury stock 1
0001333986-25-000020 6 18 EQ 0 H Stock Repurchased And Retired During Period Value us-gaap/2024 Retirement of common stock 1
0001333986-25-000020 6 19 EQ 0 H Minority Interest Decrease From Redemptions us-gaap/2024 Purchase of AB Holding units 1
0001333986-25-000020 6 20 EQ 0 H Minority Interest Decrease From Distributions To Noncontrolling Interest Holders us-gaap/2024 Dividends paid to noncontrolling interest 1
0001333986-25-000020 6 21 EQ 0 H Dividends Common Stock us-gaap/2024 Dividends on common stock 1
0001333986-25-000020 6 22 EQ 0 H Dividends Preferred Stock us-gaap/2024 Dividends on preferred stock 1
0001333986-25-000020 6 23 EQ 0 H Stock Redeemed Or Called During Period Value us-gaap/2024 Redemption of preferred stock 1
0001333986-25-000020 6 24 EQ 0 H Net Income Loss Portion Attributable To Non Redeemable Noncontrolling Interest 0001333986-25-000020 Net income (loss) 0
0001333986-25-000020 6 25 EQ 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Other comprehensive income (loss) 0
0001333986-25-000020 6 26 EQ 0 H Stockholders Equity Other us-gaap/2024 Other 1
0001333986-25-000020 6 27 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Balance, end of period 0
0001333986-25-000020 7 1 EQ 1 H Common Stock Dividends Per Share Declared us-gaap/2024 Cash dividends declared per common share (in dollars per share) 0
0001333986-25-000020 8 2 CF 0 H Profit Loss us-gaap/2024 Net income (loss) 0
0001333986-25-000020 8 4 CF 0 H Interest Credited To Policyholders Account Balances us-gaap/2024 Interest credited to policyholders account balances 0
0001333986-25-000020 8 5 CF 0 H Insurance Commissions And Fees us-gaap/2024 Policy charges and fee income 1
0001333986-25-000020 8 6 CF 0 H Derivative Gain Loss On Derivative Net us-gaap/2024 Net derivative (gains) losses 1
0001333986-25-000020 8 7 CF 0 H Credit And Intent To Sell Losses On Available For Sale Debt Securities And Loans 0001333986-25-000020 Credit and intent to sell losses on available for sale debt securities and loans 0
0001333986-25-000020 8 8 CF 0 H Gain Loss On Investments us-gaap/2024 Investment (gains) losses, net 1
0001333986-25-000020 8 9 CF 0 H Gain Loss On Sale Of Business us-gaap/2024 (Gains) losses on businesses held-for-sale 1
0001333986-25-000020 8 10 CF 0 H Net Investment Net Realized And Unrealized Gain Loss On Trading Securities 0001333986-25-000020 Realized and unrealized (gains) losses on trading securities 1
0001333986-25-000020 8 11 CF 0 H Income Loss Due To Novation In Pre Tax Net Income 0001333986-25-000020 Loss on novation 1
0001333986-25-000020 8 12 CF 0 H Increase Decrease In Asset Retirement Obligations us-gaap/2024 AB Retirement plan losses 0
0001333986-25-000020 8 13 CF 0 H Increase Decrease In Employee Related Liabilities us-gaap/2024 Non-cash long term incentive compensation expense 0
0001333986-25-000020 8 14 CF 0 H Other Depreciation Amortization And Accretion 0001333986-25-000020 Amortization and depreciation 1
0001333986-25-000020 8 15 CF 0 H Liability For Future Policy Benefit Remeasurement Gain Loss us-gaap/2024 Remeasurement of liability for future policy benefits 1
0001333986-25-000020 8 16 CF 0 H Market Risk Benefit Change In Fair Value Gain Loss us-gaap/2024 Change in market risk benefits 1
0001333986-25-000020 8 17 CF 0 H Equity Income Loss From Limited Partnerships 0001333986-25-000020 Equity (income) loss from limited partnerships 0
0001333986-25-000020 8 19 CF 0 H Increase Decrease In Broker Dealer Related Receivables Payables Net us-gaap/2024 Net broker-dealer and customer related receivables/payables 1
0001333986-25-000020 8 20 CF 0 H Increase Decrease In Reinsurance Recoverable us-gaap/2024 Reinsurance recoverable 1
0001333986-25-000020 8 21 CF 0 H Increase Decrease In Cash And Securities Segregated Under Federal And Other Regulations 0001333986-25-000020 Segregated cash and securities, net 1
0001333986-25-000020 8 22 CF 0 H Increase Decrease In Deferred Policy Acquisition Costs us-gaap/2024 Capitalization of deferred policy acquisition costs 1
0001333986-25-000020 8 23 CF 0 H Increase Decrease In Future Policy Benefit Reserves us-gaap/2024 Future policy benefits 0
0001333986-25-000020 8 24 CF 0 H Increase Decrease In Accrued Income Taxes Payable us-gaap/2024 Current and deferred income taxes 0
0001333986-25-000020 8 25 CF 0 H Other Noncash Income Expense us-gaap/2024 Other, net 1
0001333986-25-000020 8 26 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash provided by (used in) operating activities 0
0001333986-25-000020 8 29 CF 0 H Proceeds From Sale And Maturity Of Available For Sale Securities us-gaap/2024 Fixed maturities, available-for-sale 0
0001333986-25-000020 8 30 CF 0 H Proceeds From Sale And Maturity At Fair Value Using Fair Value Option 0001333986-25-000020 Fixed maturities, at fair value using the fair value option 0
0001333986-25-000020 8 31 CF 0 H Proceeds From Sale And Collection Of Mortgage Notes Receivable us-gaap/2024 Mortgage loans on real estate 0
0001333986-25-000020 8 32 CF 0 H Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment us-gaap/2024 Trading account securities 0
0001333986-25-000020 8 33 CF 0 H Proceeds From Sale Of Short Term Investments us-gaap/2024 Short term investments 0
0001333986-25-000020 8 34 CF 0 H Proceeds From Sale And Maturity Of Other Investments us-gaap/2024 Other 0
0001333986-25-000020 8 36 CF 0 H Payments To Acquire Available For Sale Securities Debt us-gaap/2024 Fixed maturities, available-for-sale 1
0001333986-25-000020 8 37 CF 0 H Payments To Acquire Fixed Maturities At Fair Value Using Fair Value Option 0001333986-25-000020 Fixed maturities, at fair value using the fair value option 1
0001333986-25-000020 8 38 CF 0 H Payments To Acquire Mortgage Notes Receivable us-gaap/2024 Mortgage loans on real estate 1
0001333986-25-000020 8 39 CF 0 H Payments To Acquire Trading Securities Heldforinvestment us-gaap/2024 Trading account securities 1
0001333986-25-000020 8 40 CF 0 H Payments To Acquire Short Term Investments us-gaap/2024 Short term investments 1
0001333986-25-000020 8 41 CF 0 H Payments To Acquire Other Investments us-gaap/2024 Other 1
0001333986-25-000020 8 42 CF 0 H Payments For Proceeds From Derivative Instrument Investing Activities us-gaap/2024 Cash settlements related to derivative instruments, net 1
0001333986-25-000020 8 43 CF 0 H Investment In Capitalized Software Leasehold Improvements And E D P Equipment 0001333986-25-000020 Investment in capitalized software, leasehold improvements and EDP equipment 1
0001333986-25-000020 8 44 CF 0 H Payments For Proceeds From Other Investing Activities us-gaap/2024 Other, net 1
0001333986-25-000020 8 45 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash provided by (used in) investing activities 0
0001333986-25-000020 8 48 CF 0 H Proceeds From Annuities And Investment Certificates us-gaap/2024 Deposits 0
0001333986-25-000020 8 49 CF 0 H Repayments Of Annuities And Investment Certificates us-gaap/2024 Withdrawals 1
0001333986-25-000020 8 50 CF 0 H Annuities And Investment Certificates Transfer To From Separate Accounts 0001333986-25-000020 Transfers (to) from Separate Accounts 0
0001333986-25-000020 8 51 CF 0 H Payments Of Market Risk Benefits 0001333986-25-000020 Payments of market risk benefits 1
0001333986-25-000020 8 52 CF 0 H Proceeds From Repayments Of Short Term Debt us-gaap/2024 Repayment of short-term financings 0
0001333986-25-000020 8 53 CF 0 H Increase Decrease In Collateralized Pledged Assets 0001333986-25-000020 Change in collateralized pledged assets 0
0001333986-25-000020 8 54 CF 0 H Increase Decrease In Collateralized Pledged Liabilities 0001333986-25-000020 Change in collateralized pledged liabilities 1
0001333986-25-000020 8 55 CF 0 H Increase Decrease In Bank Overdrafts 0001333986-25-000020 (Decrease) increase in overdrafts payable 0
0001333986-25-000020 8 56 CF 0 H Proceeds From Issuance Of Long Term Debt us-gaap/2024 Issuance of long-term debt 0
0001333986-25-000020 8 57 CF 0 H Proceeds From Collateralized Loan Obligations 0001333986-25-000020 Proceeds from collateralized loan obligations 0
0001333986-25-000020 8 58 CF 0 H Repayments Of Collateralized Loan Obligations 0001333986-25-000020 Repayment of collateralized loan obligations 1
0001333986-25-000020 8 59 CF 0 H Proceeds From Issuance Of Debt Consolidated Variable Interest Entity 0001333986-25-000020 Proceeds from notes issued by consolidated VIEs 0
0001333986-25-000020 8 60 CF 0 H Repayments Of Issuance Of Debt Consolidated Variable Interest Entity 0001333986-25-000020 Repayment of notes issued by consolidated VIEs 1
0001333986-25-000020 8 61 CF 0 H Payments Of Dividends Common Stock us-gaap/2024 Dividends paid on common stock 1
0001333986-25-000020 8 62 CF 0 H Payments Of Dividends Preferred Stock And Preference Stock us-gaap/2024 Dividends paid on preferred stock 1
0001333986-25-000020 8 63 CF 0 H Purchase Of Noncontrolling Interests For Share Based Compensation Plan 0001333986-25-000020 Purchase of AB Holding Units to fund long-term incentive compensation plan awards, net 1
0001333986-25-000020 8 64 CF 0 H Payments For Repurchase Of Common Stock us-gaap/2024 Purchase of treasury shares 1
0001333986-25-000020 8 65 CF 0 H Payments To Redemptions From Noncontrolling Interests 0001333986-25-000020 Purchases (redemptions) of noncontrolling interests of consolidated company-sponsored investment funds 1
0001333986-25-000020 8 66 CF 0 H Payments To Minority Shareholders us-gaap/2024 Distribution to noncontrolling interest of consolidated subsidiaries 1
0001333986-25-000020 8 67 CF 0 H Increase Decrease In Securities Lending Payable us-gaap/2024 Change in securities lending 0
0001333986-25-000020 8 68 CF 0 H Proceeds From Payments For Other Financing Activities us-gaap/2024 Other, net 0
0001333986-25-000020 8 69 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by (used in) financing activities 0
0001333986-25-000020 8 70 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Effect of exchange rate changes on cash and cash equivalents 0
0001333986-25-000020 8 71 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Change in cash and cash equivalents 0
0001333986-25-000020 8 72 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents, beginning of period 0
0001333986-25-000020 8 73 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Held For Sale Including Exchange Rate Effect 0001333986-25-000020 Change in cash of businesses held-for-sale 0
0001333986-25-000020 8 74 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents, end of period 0
0001333986-25-000020 8 76 CF 0 H Right Of Use Asset Obtained In Exchange For Operating Lease Liability us-gaap/2024 Right-of-use assets obtained in exchange for lease obligations 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.